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Summary
Even though trace elements are present at minute amounts in the human 
body, they have a considerable impact on human health, either as essential 
elements in biochemical functions indispensable for life, or on the contrary, 
interfering with vital processes. Knowledge of the optimal concentrations of 
trace elements in the human body is therefore of great importance. Since the 
first systematic determinations of trace elements in human body fluids 
started in the 1940s there has been an incredible development in analytical 
instrumentation. The objective of this thesis is to demonstrate successful 
applications of HR-ICP-MS (high resolution inductively coupled plasma 
mass spectrometry) in biomedicine. 
Research on trace elements in humans is challenging because of very low 
levels and many different types of matrices. The first important issue 
regarding trace element analysis is sampling and sample storage. It is 
essential to control all possible sources of contamination and other factors 
that can influence the concentrations. Preservation of biological samples is 
often required, and effects of the frequently used preservation and storage of 
biological tissue in formalin have been examined in this work. The 
concentrations of 20 trace elements were determined in formalin where 
brain samples had been stored at different time intervals ranging from few 
weeks to several years. The results show that storage of biological tissue in 
formalin may result in losses of trace elements from the tissue to the 
formalin, and that the leakage is time-dependent. This emphasizes the 
importance of controlling all steps from sample collection to analysis. 
With its low detection limits, high resolution and multielement capability, 
HR-ICP-MS offers a considerable potential for further understanding the 
role of trace elements in biological material. These features were used to 
develop a method to study protein-bound metals in cerebrospinal fluid 
(CSF). CSF samples from eight healthy persons were separated by size 
exclusion HPLC and the resulting fractions were analyzed using HR-ICP-
MS. The major challenge in this work was the very low concentrations as 
only 100 μl CSF was injected to the column resulting in 35 fractions of 0.75 
ml. It was possible to determine more than 10 elements of clinical interest in 
the CSF fractions and the method provides an opportunity to study MT and 
other metal binding proteins in CSF.  
Further, the potential to study exposure and intake of trace elements by HR-
ICP-MS was explored by analyzing hair strands of five occupationally 
unexposed subjects. The trace element profiles of single hair strands were 
determined by analyzing 1 cm long segments. The challenge in this study 
                                                                                                              5 
was again the extremely small sample size, as the samples had an average 
weight of 0.05 mg. It was possible however to obtain results for 12 elements 
in these minute samples and valuable information about intake and exposure 
for Hg, Se and Sr was obtained. 
HR-ICP-MS has the potential to be an excellent tool for obtaining 
information about disease development and progress. A rare and relatively 
unexplored neurodegenerative disease (Skogholt’s disease) was studied. The 
trace element concentrations in whole blood, plasma and CSF were 
determined in Skogholt patients, multiple sclerosis patients and controls. 
Increased levels of Cu, Fe, Zn, Se and S in CSF were found in CSF from 
Skogholt patients. These increased levels were not reflected in blood, and it 
is quite obvious that the increased levels are not caused by increased 
environmental exposure. The results suggest that the increased levels of 
these elements in CSF are due to a leakage of metal binding proteins from 
blood to the CSF.
Trace elements have been implicated in the development of Parkinson’s 
disease (PD), and a study was performed on trace elements in serum from 
Parkinson patients collected in 1995-97, 4-12 years before they were 
diagnosed with the disease. New samples from more than half of these 
patients were collected in 2007. No significant differences were found 
between preclinical levels and controls, except for a lower level of Hg in the 
patient group. However, when trace element serum levels in patients from 
before and after they were diagnosed were compared, significant differences 
for several elements were found. This suggests that trace element 
imbalances found in PD patients may be a result of disease development 
rather than a causal factor.  
HR-ICP-MS offers a considerable potential for further understanding the 
role of trace elements in humans. Biological material is often available for 
analysis only in small amounts. HR-ICP-MS gives the opportunity of 
simultaneous quantification of many trace elements even in very small 
samples and with very low detection limits. This promotes new research in 
the field of trace elements in biological material. HR-ICP-MS also reduces 
the time and cost per analysis and broadens the amount of information 
available from a single specimen.  
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Introduction

1.1 Trace elements in humans 
1.1.1 Introduction 
Trace elements are often defined as those elements having concentrations 
less than 100 mg/g (0.01%) in the human body (Peereboom, 1985). Another 
definition of a trace element is all naturally occurring elements in the 
periodic table, except minor and major elements and noble gases (Lindh, 
2005). The major elements (H, O, C and N) make up 96% of the human 
body, whereas the minor elements (Na, K, Ca, Mg, P, S and Cl) comprise 
3.8% of the human body (Lindh, 2005). There are 90 naturally occurring 
elements in the Periodic Table, and by this definition, the trace elements 
include 73 elements. Of these 73, 18 elements are considered to be essential 
or possibly essential trace elements: Li, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, W, 
Mo, Si, Se, F, I, As, Br and Sn (Lindh, 2005). A definition of an essential 
element is given by Mertz (Mertz, 1981):  
An element is essential when a deficient intake consistently results in an 
impairment of a function from optimal to suboptimal and when 
supplementation with physiological levels of this element, but no other, 
prevents or cures this impairment. 
Essential trace elements are required at optimum levels for a number of 
metabolic and physiological processes in the human body typically in 
amounts ranging from 50 μg to 18 mg per day (Mertz, 1981). However, 
excess concentrations of both essential and non-essential metals can be toxic, 
while insufficient levels may lead to metabolic failure.
1.1.2 Functions of trace elements 
Trace elements have many important functions in the human body. The 
most important functions are as co-factors in essential enzymes and proteins, 
stabilizers in membranes (e.g. Zn in biomembranes), elements of structures, 
and essentiality for hormonal function (e.g. iodine in thyroid hormones) 
(Peereboom, 1985). Zinc, for example, is known to be an essential co-factor 
in at least 100 enzymes and is important for DNA transcription and 
regulation (Peereboom, 1985).  
Essential elements are subject to homeostatic control mechanisms that may 
include absorption, excretion as well as tissue retention. It is important to 
ensure a safe and optimum supply of essential trace elements for the 
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performance of essential functions. Any essential element becomes toxic 
when it enters an organism in large amounts. On the other hand, inadequate 
intake may impair cellular and physiological function and often causes 
illness. Fig. 1 illustrates the relation between a biological function and the 
concentration in the body or dietary intake of a trace element. The increase 
is followed by a plateau representing the maintenance of optimal function 
through homeostatic regulation, and a decline of the function toward zero as 
the regulatory mechanisms are overcome by increasing concentrations that 
become toxic (Mertz, 1981). Each element has its own specific curve, which 
differs from that of other trace elements (for example the width of the 
plateau), but the model is probably applicable to most essential trace 
elements. Two conclusions from this model are important: 1) for each 
element there is a range of safe and adequate exposures, within which 
homeostasis is able to maintain optimal tissue concentrations and function; 
2) every trace element is potentially toxic when the range of adequate and 
safe exposure is exceeded (Mertz, 1981).
Figure 1. Dose-response curve for essential trace elements (Mertz, 1981). 
The figure is reproduced after Flaten (1997). 
1.1.3 Deficiency 
Deficiency of trace elements may be caused by inadequate nutrition. The 
world’s most prevalent nutritional disorder is iron deficiency (Menkes, 
1997). Iodine deficiency is also a widespread problem, affecting hundreds of 
millions of people worldwide (Hetzel, 2005). In fact, iodine is probably the 
first trace element to be associated with a human disease and salts of iodine 
was used therapeutically as early as in 1820 (Smith, 1987). Iodized salt have 
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proven to be very effective in preventing iodide deficiency disorders all over 
the world and has substantially reduced goitre caused by iodine deficiency. 
Deficiencies can also originate from genetic or inherited disorders in trace 
element metabolism. Inherited neurological disorders in which metals are 
involved in the pathogenesis have been described, e.g. Menke’s disease and 
acrodermatitis enteropathica. Menkes’ disease is a genetic copper deficiency 
disorder were copper transport is disrupted (Menkes, 1999). The disease is 
usually fatal in early childhood. Acrodermatitis enteropathica is a rare 
autosomal recessive disorder where a decrease in Zn absorption leads to Zn 
deficiency (Krogh and Syversen, 1975). 
1.1.4 Toxicity 
Paracelsus (1493-1541) stated that everything is toxic; it is just a matter of 
dose. Essential elements can also be toxic if excessive amounts are ingested. 
Manganese, for example, is an essential trace element in the human diet, but 
occupational exposure (e.g. mine-workers) shows that such inhalation can 
trigger psychotic behaviour and Parkinson-like symptoms, also called 
manganism (Mena and Marin, 1967). Arsenic poisoning is a problem of 
increasing recognition. Due to contamination by natural geological 
occurrence, arsenic is present in high amounts in drinking water in 
Bangladesh and other Asian countries, causing poisoning of the population 
(Mukherjee et al., 2006). Some elements such as cadmium, lead and 
mercury are classically catalogued as toxic elements since they have 
deleterious effects even at very low levels (Versieck and Cornelis, 1989). 
There are many examples of severe poisoning by these elements. Pb is 
neurotoxic at very low concentrations (Skerfving and Bergdahl, 2007), in 
fact during the last 2-3 decades the blood lead level considered safe has 
decreased from more than 20 to less than 10 μg/dl.  Pb has even been 
implicated in the downfall of the Roman Empire, as the ruling classes had 
lead piping installed in their homes and drank from goblets containing lead 
(Nriagu, 1983). Mercury is also highly neurotoxic and the world’s largest 
environmental mercury poisoning was discovered in Minamata, Japan, in 
1956. Severe poisoning with many fatal cases and prenatal poisonings 
occurred and the source of poisoning was fish and shellfish heavily 
contaminated by industrial discharge of mercury into the local waters 
(Harada, 1995). In Iraq, several hundred farmers died after eating seed grain 
dressed with methylmercury (Bakir et al., 1973).  
12
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1.1.5 Interactions 
The effects of deficiencies and toxicity of trace elements do not solely 
depend on the levels at which they are present, but also on a number of other 
factors (Becking et al., 2007): 
- the chemical form,  
- food source or dietary matrixes,  
- age,
- gender,
- nutritional state,
- interaction with other elements.  
Speciation, which means the specific form in which an trace element is 
present in a certain matrix, is of outmost importance. As an example, water-
soluble As salts are carcinogenic to man, whereas As bound to proteins 
(organic) have a low toxicity (Peereboom, 1985). Many toxic and essential 
trace elements are interrelated in some way, mainly because of similar 
chemical characteristics. This may cause biological effects, as there is a lack 
of complete specificity of mechanisms involved in absorption, transport and 
bio-interaction of the individual metals. Such interactions can both enhance 
adverse effects and protect against toxicity. In general, a deficiency of 
essential elements may increase toxicity of heavy metals, while an excess in 
many situations is protective. For example, a deficiency of Ca, Fe or Zn, 
enhances susceptibility of Cd and Pb toxicity (WHO, 1996), while selenium 
protects against mercury toxicity by binding the mercury in large proteins 
(Flaten, 1997). A classical example of element-element interactions is that a 
high intake of Mo may induce Cu deficiency in ruminants (Mills and Davis, 
1987).
1.1.6 Metalloproteins 
One-third of all proteins are metalloproteins, chemical combinations of 
protein atoms (carbon, nitrogen, oxygen, hydrogen, sulphur) with ions of 
metals such as iron, calcium, copper, and zinc. Metalloproteins have 
important roles in the availability and uptake of trace elements as well as in 
transport and storage. The haemoglobin, for example, that carries oxygen in 
the bloodstream, is an iron-containing metalloprotein (Morris, 1987). The 
metal ions in metalloproteins are critical to the protein's function, structure, 
or stability. In fact, numerous essential biological functions require metal 
ions, and most of these metal ion functions involve metalloproteins. 
Metalloproteins are involved in electron transport, oxygen storage, metal 
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transport, chemical bond hydrolysis, redox processes, and synthesis of 
biological compounds (Lindh, 2005). 
An important sub-group of metalloproteins is metallothioneins (MT). 
Metallothioneins are low molecular weight intracellular proteins with a 
unique capacity to bind 7 metal ions through 20 sulphydryl groups 
(Nordberg, 1998). High concentrations of the protein are found in liver, 
kidney, intestine and pancreas. It is thought to be involved in the regulation 
of copper and zinc metabolism, and in the detoxification of heavy metals 
(Nordberg and Cherian, 2005). Four major forms of MT have been 
described: MT-1, MT-2, MT-3 and MT-4 (Nordberg et al., 1971). MT is an 
inducible protein, and its synthesis can be induced in response to many 
substances, including zinc, cadmium, copper, mercury and some non-
metallic compounds.  Abnormalities in MT have been reported in multiple 
neurological disorders (Aschner and West, 2005) and it is possible that MTs 
may have important roles in several human neurological diseases such as 
Alzheimer’s disease, Parkinson’s disease  and amyotrophic lateral sclerosis  
(Johansson et al., 2005; Hozumi et al., 2004; Roos et al., 2006; Barany et al., 
2002; Forte et al., 2004). 
1.1.6 Trace elements and neurodegenerative disorders 
The pathogenesis and aetiology of neurodegenerative disorders such as 
Parkinson’s disease, amyotrophic lateral sclerosis, and Alzheimer’s disease 
are still unknown. Trace elements have been implicated in the pathogenesis 
and/or aetiology of several neurodegenerative diseases (Sayre et al., 2000; 
Zatta et al., 2003). The redox-active transition metals Cu and Fe seem to be 
involved in mediating the processes leading to oxidative stress. 
Considerable evidence implicates crucial roles of oxidative stress in the 
pathogenesis of major neurodegenerative disorders (Halliwell, 2006). Mn is 
a neurotoxic trace element and overexposure of Mn can cause manganism, a 
neurological syndrome that resembles Parkinson’s disease (Mena and Marin, 
1967; Dobson et al., 2004). Accumulation of Al in the brain is often found 
in Alzheimer type neurofibrillary degeneration and Al has therefore been 
suspected to be involved in the pathogenesis of Alzheimer’s disease 
(Crapper et al., 1973; Flaten, 2001). 
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1.2 Trace element determinations in biological material 
The determination of trace elements in biological fluids and tissues serves 
several purposes, including quantification of essential trace elements in 
normal and disease condition, detection of potentially toxic metals, and 
diagnosis of trace element deficiency and trace element related diseases (e.g. 
(Heitland and Köster, 2006; Schütz et al., 2005; McDiarmid et al., 2006; 
Carrizales et al., 2006; Chen et al., 2007; Forte et al., 2005; Rodushkin et 
al., 2000; Kassu et al., 2005). The accurate determination of 
environmentally and occupationally relevant trace elements can be an 
important tool in the assessment of exposure, diagnosis and treatment of 
adverse health effects (Gellein et al., 2008b).  
Biological materials are difficult matrices for trace element analysis because 
they contain large amounts of proteins, inorganic salts and small organic 
molecules, which may cause serious matrix effects (Marchante-Gayón, 
2004). However, advances in instrumentation over the past 1-2 decades have 
led to extraordinary improvements in the precision and sensitivity of trace 
element analysis. The most common techniques used for trace element 
determination in human biological material are flame atomic absorption 
spectrometry (flame AAS), graphite furnace atomic spectrometry (graphite 
AAS), inductively coupled plasma atomic emission spectrometry (ICP-
AES) and inductively coupled plasma mass spectrometry (ICP-MS).  
1.2.1 Atomic absorption spectrometry 
Atomic absorption spectrometry (AAS) has frequently been used for the 
determination of trace elements in a wide range of materials. The methods 
measure the amount of energy (in the form of photons of light) absorbed by 
the sample. Ultraviolet and visible atomic spectra are obtained by 
converting the components of a sample into atoms or elementary ions by 
suitable heat treatment (Slavin, 1994). The light source is usually a hollow 
cathode lamp, which contains the same element as that to be determined. 
The precision and accuracy of atomic methods are critically dependent upon 
the atomization step. Atomization of the compound in solution can be 
achieved either by introducing the sample into a flame (flame AAS), or by 
introducing the sample into a graphite tube where it is heated electrically to 
convert the sample into a cloud of free atoms (graphite AAS).  
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Table 1. Flame AAS 
Advantages Drawbacks
- simple and easy 
- low costs 
- high reproducibility 
- high precision 
- high detection limit 
- sample volume (several ml) 
- traditionally a single element 
technique
Table 2. Graphite AAS 
Advantages Drawbacks
- relatively low cost 
- small sample volume (10-100μl) 
- low detection limit 
- slow ( >2 min pr. sample) 
- traditionally a single element 
technique
1.2.2 Inductively coupled plasma atomic emission spectrometry 
Inductively coupled plasma is an electrical conducting gaseous mixture of 
argon, argon ions and electrons. The plasma is formed from a stream of 
argon gas, which is energized by a high-energy, radio-frequency field 
(Montaser et al., 1998). This leads to high atomization and ionization of the 
flowing argon and an excitation temperature of 5500-8000°K is generated 
(Montaser et al., 1998). The sample is introduced into the plasma as an 
aerosol and the high temperature causes a very efficient desolvation, 
volatilization, atomization, excitation and ionization of the sample 
(Montaser et al., 1998). ICP-AES is a type of emission spectrometry that 
uses the ICP to produce excited atoms that emit electromagnetic radiation at 
a wavelength characteristic of a particular element. The intensity of this 
emission is used to determine the concentration of the element within the 
sample.  
Table 3. ICP-AES 
Features Drawbacks
- multielement capacity 
- high precision 
- high detection limits 
1.2.3 Inductively coupled plasma mass spectrometry
The very high temperature of the argon plasma and its effectiveness as an 
ionization source were further applied in the development of ICP-MS in 
1980 (Houk et al., 1980). The ICP-MS instrument combines the plasma as 
ion source with a mass spectrometer. Quadropole (Q) mass analyzers have 
been the most popular mass filters in ICP-MS owing to their relatively low 
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costs and easy handling (Marchante-Gayón et al., 1999). The main 
limitation of these instruments is their low resolution power and 
consequently the presence of spectral interferences caused by ions having 
the same nominal mass as the isotope measured (Marchante-Gayón et al., 
1999). The interferences are particularly frequent and severe in the region 
under 80 Da, which includes most of the elements of biomedical interest. 
Table 4. Q-ICP-MS 
Advantages Drawbacks
- multielement capacity 
- low detection limits 
- high sensitivity 
- wide linear range 
- isotope ratio determinations 
- high cost 
- requires skilled personnel 
- suffers from spectral interferences 
1.2.4 High Resolution ICP-MS 
As mentioned above the Q-ICP-MS suffers from several types of non-
spectral and spectral interferences, which constitute the principal limitations 
of the technique. Interferences in the analysis of complex matrices, such as 
human body fluids containing high amounts of inorganic and organic 
components are especially challenging. Many of these spectral interferences 
can now be overcome by high resolution ICP-MS, also called sector field or 
double focusing ICP-MS. The HR-ICP-MS combines a magnetic sector 
(mass focusing) with an electrostatic sector (energy focusing) which makes 
it possible to separate ions with the same mass-to-charge ratio but slightly 
different energies (Marchante-Gayón et al., 1999). The mass resolution 
offered by the HR-ICP-MS is sufficient to separate most of the common 
spectral interferences. The HR-ICP-MS is characterized by a low 
instrumental background, which yield superior detection limits at low 
resolution (Moens et al., 1995).
Table 5. HR-ICP-MS 
Advantages Drawbacks
- multielement capacity 
- very low detection limits 
- high sensitivity 
- high resolution 
- excellent linear range 
- low instrumental background 
- isotope ratio determinations 
- high investment cost 
- high running and maintenance cost 
- requires highly skilled personnel 
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1.2.5 Trace element speciation
To elucidate the metabolism, bioavailability and toxicity of a metal, it may 
not be sufficient to determine the total concentration of the metal (de la 
Calle Guntiñas et al., 2002). Knowledge of the binding of trace elements to 
the different proteins, and other aspects of speciation of trace elements in 
biological systems is therefore of increasing interest. HR-ICP-MS is a very 
powerful detector for trace element speciation using e.g. high performance 
liquid chromatography (HPLC) or gas chromatography separations because 
of its selectivity and extremely high sensitivity (Bergomi et al., 2002; Wang 
et al., 1999; Gellein et al., 2007).
1.3 Challenges in sampling and analysis 
1.3.1 Sample collection and contamination control 
Contamination is by far the most important source of error in the 
determination of trace elements. Trace elements are ubiquitous in the earth’s 
crust and may enter the samples at all phases of sample preparation and 
analysis. The increasing sensitivity of analytical methods has resulted in the 
use of decreasing amounts of the analyte in question, and the effect of even 
low-level contamination may be disastrous. Appropriate measures must 
therefore be taken to avoid contamination of the samples. 
Sample collection is the first critical step in trace element analysis of human 
samples (Rodushkin and Ödman, 2001). Guidelines for sample collection in 
blood and urine have been developed (Cornelis et al., 1996), however such 
guidelines are not always possible to follow stricktly. When biological 
fluids such as blood and cerebrospinal fluid are collected, the use of needles 
is necessary. Stainless steel needles are commonly used in clinical practice. 
These needles can contaminate the sample, especially of Mn, Ni, Cr and Co 
(Aito and Järvisalo, 1994). It is therefore preferable to use a siliconized 
needle (Ericson et al., 1986). The collecting tubes for whole blood are 
equipped with self-sealing rubber stoppers that inevitably will come in 
contact with the blood. Such rubber products frequently contain metals as 
e.g. material modifiers. Anticoagulants are another source of potential 
contamination of blood samples. If possible, blood collection containers 
manufactured especially for trace element analysis should be used, and the 
needle should be flushed with at least 5-10 ml blood before the sample is 
collected.
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Biological specimens undergo numerous transformations when kept at room 
temperature and preservation of samples before chemical analysis is 
therefore frequently necessary. A variety of preservation methods exist, 
such as low temperature (-20 or -70 °C), lyophilization, or the addition of 
chemicals (acids and preservatives).  Formalin is an effective tissue 
preservative and is therefore often used (Meldrum, 2001). However, 
formalin can affect the sample by contaminating it as well as extracting 
elements from the sample (Gellein et al., 2008a). This should be considered 
when using formalin-fixed biological tissue in trace metal analysis. When 
possible, fresh/frozen tissue should always be considered as a preferable 
alternative. 
Modern laboratories will inevitably be contaminated by dust from the 
ventilation ducts. Depending on the building design, the dust might 
originate from concrete and/or aluminium ducts. Dust from concrete will 
likely contain trace amounts of Cr and Ni while aluminium ducts may 
release particles containing Al and Zn. If samples are exposed to such dust it 
may introduce trace metal concentrations many times higher than expected 
within the sample. 
In order to minimize blank signals it is crucial to ensure minimal exogenous 
contamination by use of purified acids, and resorting to clean-room facilities 
is also preferred. Ultrapure water must be used. All sample storage 
containers and other equipment should be acid washed polyethylene, 
polystyrene, polypropylene or Teflon – and storage must be under 
appropriate conditions.
Recognition of contamination has dramatically changed our view of the true 
concentrations of many trace elements in biological samples. It has been 
noted that published normal serum levels of e.g. Cr have fallen dramatically 
over the last 60 years (figure 2) – and the most probable explanation for this 
is the increasing awareness of sample contamination.  
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Figure 2. The apparent concentration of Cr in blood has decreased 
dramatically since 1950 (Flaten, 1988). 
1.3.2 Sample preparation 
Human biological materials have a range of both chemical and mechanical 
characteristics, e.g. hard, calcified tissues (e.g. bone, teeth), semi-hard tissue 
(e.g. hair, nails), soft body tissues and body fluids. In order to achieve a 
homogenous solution of such materials the digestion procedure must be 
designed with such differences in mind. Historically, acid digestion has 
been the most widely used technique for such preparation of biological 
samples. Oxidation is carried out by acids (HNO3, HClO4 and H2SO4 in
various combinations and sometimes also with H2O2 or HF) combined with 
heating on a hot plate with temperatures up to 200 C (Vanhoe, 1993). Hot-
plate dissolution procedures are limited by several factors: long dissolution 
times, the potential loss of volatile elements, sample contamination by 
excessive amounts of reagents, and prolonged contact with vessel materials 
(Kingston and Walter, 1998). A useful alternative to the hot plate is 
microwave heating. This method is now the dominant digestion method for 
human samples because it is more reproducible, more accurate, and less 
time consuming than conventional digestions on hot plates. Microwave 
systems keep blank levels low because only small volumes of reagents are 
required, and they allow more samples to be processed per hour than 
conventional digestion systems (Krachler et al., 1996). The digestion takes 
place in sealed quartz or Teflon bombs by heating in a microwave oven. The 
high internal pressure that develops ensures rapid digestion without any loss 
of analyte. Very little acid is lost during digestion so acid consumption can 
be limited and the blank kept minimal (Kingston and Walter, 1998).  
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The use of HNO3 for digestion of biological samples is widely favoured, as 
it introduces less interference in the analysis of biological samples by ICP-
MS than the other strong acids (Krachler et al., 1996). H, N and O do not 
add any additional spectral interference to those already existing in a pure 
water spectrum. This is in contrast to H2SO4 and HClO4, which introduce
polyatomic ions such as ClO and SO (Vanhoe, 1993). The oxidizing 
properties of nitric acid will dissolve most metals to free ions in solution. It 
has poor oxidizing strength at concentrations less than 2 M, but it is a 
powerful oxidizing agent in the concentrated form (14.5 M). Its oxidizing 
strength can be enhanced by the addition of e.g. hydrogen peroxide, or by 
increasing the reaction temperature and pressure (Kingston and Walter, 
1998). Because hydrogen peroxide is reduced to H2O, no additional 
interferences are introduced (Krachler et al., 1996). Complete digestion of 
tissue samples using microwave digestion requires at least 1 ml acid per 0.1 
g tissue (wet weight). For whole blood, the ratio should be around 1:1 (v/v), 
but for serum or CSF the amount of acid can be halved. Because the 
concentrations of many trace elements in these materials are low, dilution 
should be kept to a minimum although the concentration of elements such as 
Na and K can be high enough to cause significant suppression of 
enhancement of the ion signal (Vanhoe, 1993). 
After digestion, the samples must be diluted in order to get the appropriate 
acid concentration. Nitric acid concentrations in solutions should not be 
higher than 1.5 M for analyses by HR-ICP-MS as the signal is dependent 
upon the acid concentration. Higher concentrations cause rather rapid and 
severe corrosion of the sample and skimmer cones. The optimal nitric acid 
concentration is about 1 M. Solutions with this concentration provide 
signals that are independent of nitric acid concentration and are less 
corrosive to the cones (Krachler et al., 1996). Dilution can be done either by 
weight or in volumetric flasks. Samples should be kept in capped containers 
in the refrigerator until the analysis is carried out.   
1.4 Quality control 
1.4.1 Precision and accuracy 
In discussing chemical analysis, it is necessary to define and distinguish 
between the terms accuracy and precision. Precision is an expression of the 
repeatability of a measurement (Wolf, 1987). Generally, the precision of a 
measurement is readily determined by simply repeating the measurement. 
The term accuracy refers the closeness of a result to its true or accepted 
value (Wolf, 1987). Inaccuracy reflects the extent of systematic error in the 
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measurement. The accuracy is best determined by using a certified reference 
material. Figure 3 illustrates the difference between accuracy and precision. 
A    B    C 
Figure 3. A: high accuracy, high precision, B: low accuracy, high precision, 
C: high accuracy, low precision 
1.4.2 Reference materials 
Reference materials are important for quality control of analytical 
measurements. They are used to determine the accuracy of the method. The 
ideal would be to have a certified reference material (CRM) for every type 
of matrix. This is however not always the case and one have to use another 
reference material with approximately the same matrix. For instance, a
certified reference material for brain is unfortunately unavailable. Instead, 
bovine liver is often used as certified reference material in trace element 
analysis of brain tissue. Bovine liver contains 10% lipids and this is the 
closest to the (60%) lipid concentration in brain among the commercially 
available reference materials (Krachler et al., 1996). For whole blood, serum 
and urine there are CRMs available from several suppliers, while no CRM is 
available for cerebrospinal fluid.  
1.4.3 Internal standard and matrix effects 
Even though HR-ICP-MS instruments solve most problems caused by 
spectral interferences, they suffer from non-spectral matrix effects 
originating from the plasma and the sample introduction system. Internal 
calibration is one method to deal with this problem. Using internal 
calibration, the signal for one element is corrected or calibrated by using a 
second element as a reference point. An element with a known 
concentration, an internal standard, is then added to all solutions, including 
the blank, calibrators and unknowns. Ideally, this internal standard should 
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undergo the identical matrix suppression or enhancement as that of the 
analyte element. A close match of the mass number between the analyte and 
the internal standard is very important to effectively correct for matrix 
effects (Hsiung et al., 1997). The drawback of this method is that one can 
never be certain that the element that serves as an internal standard will 
undergo identical matrix effects as the element that is corrected. Addition of 
internal standard also increases the uncertainty of the measurement, as one 
more solution is added. An easier way to deal with this problem is to matrix 
match the standards used for calibration of the instrument. Sufficient 
dilution of the samples will also minimize the problem. 
1.4.5 Memory effects 
As a result of the high sensitivity and low instrumental background of the 
HR-ICP-MS, the instrument is highly susceptible to memory effects (Moens 
et al., 1995). Ways to deal with this problem is by carefully planning the 
sequence of the analysis. However, prolonged washing after e.g. standard 
solutions have been introduced to the instrument may also be necessary. 
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2 Summary of the individual papers 
2.1 Paper ȱ
The accurate determination of trace elements in body fluids and body tissue 
can be an important tool in the prevention and control of pollution as well as 
for the diagnosis and treatment of adverse health effects. The validity of the 
results obtained from trace element analysis however does not only depend 
on the analytical instrumentation, but also on the pre-analytical steps such as 
collection, preservation, storage, and treatment of the sample. There is 
frequently a need to preserve biological samples before chemical analysis. A 
common concern is that reagents, equipment or the environment may 
contaminate the samples, thus providing erroneous analysis. However, 
procedures may also cause loss of analyte from samples. This paper reports 
how trace element concentrations in biological tissue (brain samples) are 
effected by storage in formalin.  
The concentrations of 20 trace elements were determined in formalin in 
which brain samples had been stored for different time durations ranging 
from weeks up to several years. The study shows that when biological tissue 
is stored in formalin, trace elements may leak from the tissue into the 
formalin solution. The leakage is time-dependent, and differs among the 
elements. For some elements such as Cr and Ni, the leaching is negligible, 
while for elements such as As, Cd, Mg, Rb and Sb, the leakage is 
considerable. For the essential elements Fe, Zn and Cu, the results are 
intermediate. It seems reasonable to assume that the differences depend on 
the strength and mode of binding of the different elements in the tissue. The 
potential for leaching should always be critically considered when using 
formalin-fixed biological tissue in trace element analysis. If available, fresh 
or frozen tissue should be used. 
2.2 Paper ȱȱ
The role and effects of trace elements in the human body strongly depend on 
the chemical form in which the element is present and e.g. binding to 
various proteins. To elucidate the metabolism, bioavailability and toxicity of 
a trace element, information about trace element speciation is needed. The 
objective of this paper was to develop procedures by which binding of trace 
elements to different proteins in cerebrospinal fluid (CSF) could be studied. 
The CSF surrounds the central nervous system and is in continuous 
equilibrium with the brain and the spinal cord. Trace elements and the 
metal-binding protein metallothionein (MT) have been implicated in the 
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pathogenesis of various neurodegenerative disorders. A method to study 
metallothionein and other metal-binding proteins would therefore be very 
useful.
Samples of CSF were collected from eight normal and healthy subjects. 
Proteins in the CSF samples were separated by size exclusion 
chromatography combined with high performance liquid chromatography 
(SEC-HPLC). The column was calibrated to separate proteins in the 
molecular weight range 6-70 kDa. The resulting fractions were then 
analyzed off-line using high resolution inductively coupled mass 
spectrometry (HR-ICP-MS) to determine the concentrations of the trace 
elements in the fractions.  
The major challenge in this work was the very low concentrations, as only 
100 μl CSF was injected to the column resulting in 35 fractions of 0.75 ml. 
It was possible to determine more than 10 elements of clinical interest in the 
CSF fractions. The study also showed that it is possible to detect MT based 
on the peaks where elements Cd and Zn are eluted because of the strong 
affinity of metals to MT. The method thus provides an opportunity to study 
MT and other metal binding proteins in CSF. 
2.3 Paper ȱȱȱ
Trace element analysis of human hair can be used for the assessment of 
environmental exposure and evaluation of nutritional status. Because trace 
elements are incorporated into the hair strand during growth, the analysis of 
hair strands provides an opportunity to monitor elements over a period from 
a few weeks to several years – depending on hair length. In this paper, the 
potential of human hair to indicate exposure or nutritional status over time 
has been evaluated by analysing trace element profiles in single strands of 
human hair. Hair strands from five healthy and occupationally unexposed 
subjects were cut into 1 cm long segments starting from the scalp. The hair 
segments were analysed by HR-ICP-MS. Profiles of 12 elements in single 
strands of human hair were obtained: Ag, As, Au, Cd, Cu, Hg, Fe, Pb, Se, Sr, 
U and Zn. 
Hair is exposed to exogenous contaminants such as atmospheric pollutants, 
water, sweat and cosmetics. A challenge using trace element analysis of hair 
is therefore to differentiate between trace elements of internal and external 
origin. It was possible to correlate hair values and trace element intake for 
several elements, and valuable information about intake and exposure was 
obtained, especially for Hg, Se and Sr. For these specific elements, the 
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contamination risk is probably low, so that peaks and trends are easily 
detected independent of any pre-treatment procedures. These results 
substantiate the potential of human hair as a biomarker, even for subjects 
without any occupational exposure.
2.4 Paper ȱV
Imbalances in trace element status and exposure to toxic elements can cause 
adverse health effects. Trace element analysis of biological fluids gives us 
the opportunity to monitor and examine the trace element status of both 
healthy persons and patients. The objective of this study was to investigate 
whether changes in trace element concentrations could play a role in a rare 
familial neurodegenerative disorder called Skogholt’s disease. Using HR-
ICP-MS, 31 elements were determined in cerebrospinal fluid (CSF), blood 
plasma and whole blood from these patients, multiple sclerosis patients and 
a control group.
More than a threefold increased level of Cu and Fe, and a twofold increase 
in Zn were found in the CSF of Skogholt patients compared to controls. One 
of the characteristics of the disease is a highly increased protein level in 
CSF, and it is very likely that the elevated levels of these elements are due 
to a leakage of metal-binding proteins from the blood to CSF. Several other 
significant differences in trace element levels were also found, especially in 
the CSF.
The results from a study of trace elements in biological fluids can only 
establish whether there are any imbalances in trace element status of a 
patient group or an individual at that particular time. It is not possible to 
draw conclusions about the impact of these trace element imbalances on 
disease development and prognosis. This study shows how trace element 
analysis of biological fluids can be used to gain more information about a 
disease and possibly disease development. 
2.5 Paper V 
The aetiology of Parkinson’s disease (PD) is unknown. Trace elements have 
been implicated in the pathogenesis of the disease and changes have been 
found for several elements in biological fluids from PD patients. Such 
changes could be a cause or a consequence of the disease. The objective of 
this study was to address this issue by analysing serum from PD patients 
collected prior to as well as after they were diagnosed with the disease.  
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Samples from 34 PD patients and 102 controls were received from the 
Nord-Trøndelag Health Study (HUNT 2). These samples were collected in 
1995-97, 4-12 years before the PD patients were diagnosed with this disease. 
New samples from 19 of these patients were collected in 2007. Using HR-
ICP-MS, 21 elements were determined in the serum samples. When trace 
element concentrations from preclinical PD patients were compared with 
controls, the only significant difference found was a slightly lower content 
of Hg in the patient group than in the controls. However, when trace 
element serum levels in patients from before and after they were diagnosed 
were compared, significantly higher levels were found for Hg, Ni, and Y, 
while Ca, Fe, Mg, Mn, Rb, and Se showed lower levels. 
The results indicate that the illness may introduce changes in trace element 
homeostasis rather than the trace elements being a causative factor of PD. 
Such changes can be the result of biochemical characteristics of the illness 
itself or changes in environmental conditions associated with the illness. 
Even though the findings in this study do not provide information on how 
these changes affect the patients, it shows how trace element analysis of 
human serum can provide important information about disease development 
and progress. 

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3 Conclusions 
Trace elements have a considerable impact on human health and 
understanding the optimal concentration of trace elements in the human 
body is therefore of great importance. The principal aim of this work was to 
demonstrate the potential use of HR-ICP-MS in biomedicine. Only when 
appropriate instruments and methods are applied can analytical chemistry be 
of practical use to determine important factors in the medical science. 
Biological material is often available for analysis only in small or even 
minute amounts. The low detection limits, high sensitivity and multielement 
capability offered by HR-ICP-MS makes it possible to get accurate results 
for a wide range of elements in such samples. This has been clearly 
demonstrated in the study of trace elements in human hair, where 1 cm 
segments of a single hair strand with an average weight of 0.05 mg or less 
were analyzed. It was possible to obtain results for 12 elements in these 
minute samples and valuable time-dependent information about intake and 
exposure was obtained for Hg, Se and Sr. HR-ICP-MS was also utilized to 
develop a method to study protein-bound metals in cerebrospinal fluid (CSF) 
by coupling the HR-ICP-MS with a chromatographic method (SEC-HPLC). 
The major challenge in this work was again the small samples with very low 
concentrations It was possible to determine more than 10 elements of 
clinical interest in the CSF fractions. The separation was performed off-line 
in this work, but the HR-ICP-MS also offers the possibility of on-line 
coupling which would further enhance the chromatographic resolution. 
Biological fluids are difficult matrices to analyse because they contain large 
amounts of proteins, organic molecules and inorganic salts. HR-ICP-MS 
offers sufficient resolution to eliminate spectral interferences, which makes 
it possible to analyse almost any type of matrix. In a study of patients with a 
rare and relatively unexplored neurodegenerative disease, trace elements in 
whole blood, plasma and cerebrospinal fluid were determined. Results were 
collected from 31 elements in all three matrices and related to the disease. In 
another study, trace element analysis of serum of patients with Parkinson’s 
disease collected before and after they were diagnosed, gave information 
relevant to the disease progress. The results from this study indicate that 
previous reported trace element changes may be a result of the disease rather 
than a cause of the disease. It should be emphasized that the findings must 
be supplemented with indicators of biochemical mechanisms in order to 
provide information about how trace element imbalances may affect the 
patients. However, trace element analysis of biological fluids can, in 
appropriate combination with other studies, provide important information 
about disease development and progress. 
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In conclusion, the HR-ICP-MS is a very powerful technique for the 
determination of trace elements in biological samples. For most elements, 
the analytical technique is no longer the limiting factor. As demonstrated in 
paper ȱ, the challenge is rather to control all steps from sample collection to 
analysis. Reagent blanks and memory effects must be reduced in order to 
make fully use of the possibilities of the instrument. The advantages of HR-
ICP-MS over other techniques make it possible to achieve reliable and 
accurate results in all matrices. Thus, HR-ICP-MS offers a considerable 
potential for further understanding the role of trace elements in biomedicine. 
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Amethod to study theprotein bindingpatterns of trace elements in humancerebrospinal fluid
(CSF) is described. Proteins in CSF samples were separated by size exclusion chromatography
combined with high performance liquid chromatography (SEC-HPLC). The column was
calibrated to separate proteins in the molecular weight range 6–70 kDa. Fractions were then
analyzed off-line for trace elements using high resolution inductively coupled plasma mass
spectrometry (HR-ICP-MS). We were able to accurately determine more than 10 elements of
clinical interest in the CSF fractions. Results are presented for Cd, Mn, Fe, Pb, Cu and Zn. The
total concentrations of 16 trace elements in human plasma and CSF are also presented. The
method was able to differentiate the relative contribution of metallothionein and other
proteins towards metal binding in human CSF.
© 2007 Elsevier B.V. All rights reserved.
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1. Introduction
The central nervous system (CNS) is surrounded by cerebrospi-
nal fluid (CSF). Thus, CSF is in continuous equilibrium with the
brain and spinal cord and therefore detailed analysis of CSF has
the potential to reveal important details and malfunctions in
many diseases affecting the CNS (Hühmer et al., 2006). CSF is
largely produced by the choroid plexus and it is distributed
throughout the subarachnoid space surrounding the brain and
the spinal cord as well as the interstitial space encircling cells in
CNS. The total volume of CSF in humans is approximately
140ml,withameanproduction rateof 0.3–0.4ml/min (Sickmann
et al., 2002). The CSF contains small molecules, salt ions,
peptides, proteins and enzymes that play critical roles in many
physiological processes.Changes inCSFcompositionmayreflect
pathological processes in the CNS, and CSF therefore offers a
unique window to study CNS disorders (Yuan and Desiderio,
2005).
Trace elements play numerous roles in biology, notably as
integral parts of enzymesorprotein structures (Smithet al., 1997).
Metalloproteins are involved in electron transport, oxygen
storage, metal transport, chemical bond hydrolysis, redox
processes, and synthesis of biological compounds. Several trace
elements are essential to human health, including iron, zinc,
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copper, chromium, cobalt and molybdenum (Nordberg and
Cherian, 2005). The physiological functions of trace elements in
the human body depend on their binding to various proteins
(Richarz and Brätter, 2002). To elucidate the metabolism, bio-
availability and toxicity of ametal, it is therefore not sufficient to
determine the total concentration of the metal (de la Calle
Guntiñas et al., 2002). Also knowledge of the binding of trace
elements to the different proteins in CSF is required. We are not
aware of any published studies of speciation of trace elements in
CSF.
Metallothionein (MT) is a family of proteins with low mo-
lecular weight (6500 Da) and a unique capacity to bind 7 metal
ions through 20 sulfhydryl groups (Nordberg, 1998). Fourmajor
forms of MT have been described: MT-1, MT-2, MT-3 and MT-4
(Nordberg et al., 1971).MT is an inducible protein, and is known
to play important roles in the toxicokinetics and biochemistry
of essential as well as non-essential elements such as Zn, Cu,
Cd and Hg (Nordberg and Cherian, 2005). Abnormalities in MT
have been reported in multiple neurological disorders but
definitive links remain to be established (Aschner and West,
2005). Metals such as zinc and copper also have been
implicated as etiological factors in neurodegeneration. Taken
together, these observations suggest that MTs may have
important roles in several human neurological diseases such
as Alzheimer's disease (AD), Parkinson's disease (PD) and
amyotrophic lateral sclerosis (ALS) (Johansson et al., 2005;
Hozumi et al., 2004; Roos et al., 2006).
We wanted to develop procedures by which binding of trace
elements to different proteins in CSF could be studied. By em-
ploying size exclusion chromatography combined with high
performance liquid chromatography (SEC-HPLC), proteins in
CSF-samples were separated according to size. The resulting
fractions were then analysed off-line using high resolution in-
ductively coupledmass spectrometry (HR-ICP-MS) to determine
the concentrations of the trace elements in the fractions. Our
main interest was to establish the procedures in order to test
their usefulness in later studies of abnormalities in neurological
diseases.
2. Results
2.1. Molecular weight calibration
Table 1 shows the retention times for the standard proteins
used for calibration of the SEC-column. Albumin is the
largest protein used for calibration and thus shows the
shortest retention time. The smaller proteins then follow
according to decreasing size. Lysozyme is made up by two
different domains, four α helices form one domain and a β
sheet forms the other domain (Stryer, 1997). Since lysozyme
elutes with a double peak (21 min and 25 min), it seems
probable that these two domains have been separated during
the SEC. Fig. 1 shows the chromatogram for the calibration of
the MT peak. The double peak is probably due to a partial
overlap between MT-1 and MT-2. Wang et al. (2001) reported
that the metallothionein peak had a retention time that
corresponded to an apparent molecular weight of 13 kDa,
instead of the true molecular weight of 6.5 kDa. Their expla-
nation for this was the “dumbbell” shape of metallothioneins
that results in the occupation of a larger volume than
globular proteins with similar molecular weight. This is
also in accordance with findings on Sephadex gel chroma-
tography where MT elutes around 10 kDa which is explained
by its Stokes' radius (Nordberg et al., 1972). The elution order
Table 1 – Calibration of the size exclusion column
Protein TE MW
Albumin 10 66000
Metallothionein (MT-1+MT-2) 15 6500
Trypsin Inhibitor 16 24000
Lysozyme 21 and 25 14000
Insulin 26 5800
TE=elution time in minutes.
MW=Molecular weight (Da).
Fig. 1 – Elution profile of metallothionein by using HPLCwith Superdex 75. Metallothionein from rabbit liver was applied to the
columnand fractionswere collected eachminute. Light absorbance (mAU) at 254 nm is on the ordinate. Time (minutes) is on the
abscissa.
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of SEC is based on volume of the protein and not strictly on
the molecular weight. Thus metallothioneins often elute
earlier than would be expected from their molecular weight
(Wang et al., 2001).
2.2. Trace element profile and reproducibility
Figs. 2a and b show the profiles of Zn and Cd from the trace
element analysis of metallothionein after fractionation by
SEC-HPLC. The peaks are found at 15 min, and coincide with
the retention time of MT. Zn and Cd both binds strongly to MT
(Nordberg et al., 1971). The fact that bothmetals have the same
elution time as MT shows that they still are bound to MT after
passing through the column. In Figs. 3a–c the reproducibility of
the method is illustrated. Two CSF samples from the same
personwere fractionated by SE-HPLCwith a two-week interval
and the fractions were analysed by HR-ICP-MS. Between the
fractionations samples were stored in a refrigerator at 4 °C.
Results are shown for Cd, Cu and Fe. The reproducibility is
acceptable for the major peaks of these elements while there
are somediscrepancies forminor peaks indicating that sample
storage is important. For Cu there is one main peak at
12–13 min, while both Cd and Fe elute mainly at 17–18 min.
The peak width for these element selective chromatograms is
similar to those obtained by measuring the UV-absorbance
(λ=254 nm) (Fig. 4).
2.3. CSF
Fig. 4 shows a typical chromatogram of a CSF sample from a
normal, healthy person recorded by UV-absorption at 254 nm.
The first eluted peak in the chromatogram is albumin at
10 min. The majority of the proteins elute between 10 and
27 min. All CSF chromatograms also display a negative peak
between 22 and 23 min. The size of this peak is equal in all
chromatograms. The elution time of this peak corresponds to
the elution volume of the column. At this volume the CSF fluid
reaches the UV-detector. Since CSF has lower absorbance than
the TRIS-buffer, a negative peak is obtained. We also observed
the corresponding peak when water is injected into the SEC-
HPLC.
Trace element concentrations in CSF from the same
subject as Fig. 4 are presented in Table 3. The concentrations
of Cd, Pb, Mn, Fe, Cu and Zn are shown for each fraction. The
trace element profiles for different subjects show some
variation, but generally the major part of all trace elements
studied elute between 10 and 25 min. The total separation
Fig. 2 – Zn and Cd concentrations asmeasured byHR-ICP-MS
in fractions obtained by using HPLC with Superdex 75 and
highly purified metallothionein. Note the high similarity of
the patterns.
Fig. 3 – Reproducibility of the method shown by repeated
separation of the same CSF sample fresh from freezer (solid
line) and after 2 weeks stored at 4 °C (dotted line). 1 ml
fractions collected and subsequent analysis by HR-ICP-MS.
Elution time (in minutes) is given on the abscissa and
concentration of the metals (μg/l) on the ordinate.
μg/l=microgram per litre.
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time for a sample is 40 min. Table 2 present concentrations
of 16 trace elements in CSF and blood plasma for the study
group.
3. Discussion
A reason for scarce reports of trace elements in CSF is that
the concentrations of many elements are close to the
detection limit. This paper describes new procedures to
study trace elements in biological fluids, primarily metals in
protein fractions separated by SEC-HPLC. The separation
technique developed together with HR-ICP-MS analysis is
very useful for studying metal containing proteins in body
fluids also when metal concentrations are very low, which is
the case especially after fractionation of CSF by HPLC, which
inevitably entails a pronounced dilution (Prange and
Schaumlöffel, 2002). HR-ICP-MS has technically indeed very
low detection limits, so the operational detection limit is
determined by the reagent blank. Thus, the technique is
particularly useful for multielement analysis of small sam-
ples of biological material with low concentrations of trace
elements. Furthermore, the eluents of the HPLC have to be
tolerated by the plasma and the inlet system of the mass
spectrometer, and high organic solvent concentrations or
high salt concentrations cannot be used (Prange and
Schaumlöffel, 2002). SEC-HPLC uses a non-denaturating
mobile phase at physiological pH such as the TRIS-buffer,
which stabilizes the original metalloprotein complexes and is
easily tolerated by the HR-ICP-MS system (Prange and
Schaumlöffel, 2002). No sample preconcentration is needed
using this method.
A disadvantage of SEC-HPLC for MT analysis is that MT-1
and MT-2 isoforms cannot be distinguished (Lobinski et al.,
1998). But better separations can be accomplished by using a
longer column with a narrower molecular weight separation
(Wang et al., 2001).
Desorption of weakly bound metals from proteins as well
as adsorption to and release from a column may cause
problems during HPLC separation of metalloproteins. Howev-
er, no such problems were observed for the metals Zn and Cd
bound to metallothionein, probably due to the strong coordi-
nation of Cd and Zn by mercapto groups (Hozumi et al., 2004).
This can also be observed in Figs. 2a and b. This study shows
that it is possible to detect MT based on the peaks where
Fig. 4 – Chromatogram of CSF from a normal healthy subject using separation by SEC-HPLC. Light absorbance (mAU) at 254 nm
is on the ordinate. Elution time (in minutes) is on the abscissa. Trace element composition presented in Table 3.
Table 2 – Trace element concentrations in CSF and blood
plasma from eight healthy subjects
Element Unit CSF Serum
Mean S.E.M. Mean S.E.M.
Cd μg/l 0.09 0.02 0.14 0.03
Sn μg/l 0.23 0.08 0.37 0.08
Hg μg/l 0.32 0.12 0.46 0.11
Pb μg/l 1.32 0.2 bd.l. bd.l.
Mg mg/l 29.2 0.8 21.9 0.8
Al μg/l 27.68 4.29 13.7 1.42
V μg/l 0.08 0.01 0.06 0.00
Cr μg/l 0.44 0.09 0.29 0.06
Mn μg/l 2.32 0.54 0.62 0.08
Fe μg/l 74.8 25.2 1044 76
Ni μg/l 5.64 2.14 0.63 0.26
Cu μg/l 22.3 2.23 1129 124
Zn μg/l 58.6 17.2 746 44.3
Rb μg/l 47.5 3.2 166 13.1
K mg/l 112 3 162.5 6
Se μg/l 1.60 0.15 80.8 4.44
Average is the arithmetic average and S.E.M. is the standard error of
the mean.
μg/l=microgram per litre.
mg/l=milligram per litre.
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elements Cd and Zn are eluted as these metals have an
extraordinary high affinity to MT.
4. Experimental procedures
4.1. Subjects
CSF was collected during 2005–2006 from outpatients enrolled
from the waiting list for routine spinal tap at the Department of
Neurology, Ullevaal University Hospital, Oslo, Norway. These
were outpatients with minor or unspecific complaints such as
headache, concernabouthavinganeurological disorder, tingling
sensations in a limb or suspected tick bite. A fullmedical history
was recorded for each patient through the neurological follow-
up.Among thesepatients CSFwasaccepted as control only if the
final workup showed no signs of a neurological disorder. The
spinal tap was thus performed on patients receiving spinal tap
for other reasons than this study. Aliquots were taken aside for
the present study. Informed consent was received from each
patient in writing. Table 4 shows indication for spinal tap and
final diagnosis for each patient. Occupation and smoking status
as well as sex and year of birth is also shown.
Ethical approval for this study has been granted by the
ethical committees inOslo (470-03140) andStockholm (03-353).
4.2. Sample collection
Cerebrospinal fluid (CSF) was collected using a standard
Spinocan syringe 0.9×88 mm with Quincke cut provided by B.
Table 3 – Trace element concentration in fractions of CSF
after SEC-HPLC
Minutes Cd Pb Mn Fe Cu Zn
100⁎μg/l 100⁎μg/l 10⁎μg/l μg/l 10⁎μg/l 10⁎μg/l
1 3.3 1.8 0.0 0.2 0.1 1.6
2 3.4 1.2 0.0 0.0 0.0 0.0
3 3.6 2.3 5.0 0.0 6.9 0.9
4 2.9 1.0 12.9 0.0 0.0 0.0
5 2.0 0.2 22.9 0.2 0.0 0.4
6 0.0 0.0 1.0 0.0 1.2 0.0
7 0.0 0.0 0.0 0.0 0.5 0.1
8 0.0 0.0 0.0 0.0 0.0 0.2
9 0.0 0.0 0.0 0.0 0.0 0.0
10 0.0 0.0 0.0 0.4 0.0 0.6
11 0.6 0.0 0.3 0.1 0.4 0.0
12 0.8 0.0 0.7 1.0 8.1 0.0
13 0.2 0.0 0.3 0.5 2.5 0.0
14 4.1 0.0 1.1 1.1 1.1 0.0
15 9.8 0.0 1.0 0.0 0.6 0.0
16 11.6 0.0 1.3 0.0 1.4 3.2
17 15.2 0.0 0.4 62.6 0.4 0.0
18 14.5 7.9 20.1 97.9 6.6 4.0
19 12.4 8.8 26.9 18.9 0.2 0.0
20 5.2 0.0 0.0 4.8 0.1 176.2
21 3.0 0.0 0.0 1.3 0.0 0.0
22 2.4 0.0 0.0 0.8 0.0 0.0
23 1.7 0.0 0.0 0.2 0.0 0.0
24 0.8 0.0 0.0 0.3 0.6 0.0
25 0.6 0.0 0.0 0.2 0.0 0.0
26 0.3 0.0 0.0 0.6 0.0 0.0
27 0.1 0.0 0.0 0.7 0.0 0.0
28 0.0 0.0 0.0 0.1 0.0 0.0
29 0.0 0.0 0.0 0.0 0.0 0.0
30 0.0 0.0 0.0 0.0 0.0 0.0
31 0.0 0.0 0.0 0.4 0.0 0.0
32 0.0 0.0 0.0 0.0 0.0 0.0
33 0.0 0.0 0.0 1.2 0.0 0.0
34 0.0 0.0 0.0 0.0 0.0 0.0
35 0.0 0.0 0.0 0.0 0.0 0.0
Measured values below the detection limits (3*S.D. of the blank
reading) are denoted as 0 in the table. Note that values for some
elements have been adjusted by a factor (row 2) to enhance the
readability of the table. The data are from one subject.
UV-absorption profile presented in Fig. 4.
⁎=multiplied.
μg/l=microgram per litre.
Table 4 – Clinical characteristics of subjects
Sex Born Indication Diagnosis Smoker Occupation
1 M 1947 Concern None No Salesperson
2 F 1979 Headache Neck pain No Preschool
teacher
3 F 1928 Muscle
twisting
Brain stem
infarction
No Nurse
4 F 1927 Arm pain Arm pain No Housewife
5 M 1941 Paresthesias Diabetes No Clerk
6 F 1975 Tick bite None Yes Welfare
officer
7 M 1974 SAH⁎ Amaurosis
fugax
No Civil
engineer
8 F 1977 Concern None No Train
hostess
⁎Subarachnioidal hemorrhage.
M=male, F=female.
Smoker: current status of smoking.
Occupation equals occupation at the time of examination.
Table 5 – Detection limits and determined concentrations
of trace elements in the standard reference material
Seronorm Serum Level 1
Element Average values Certified values IDL DL
Al 30.0 36.4 0.2 4.11
Cd 0.39 0.39 0.002 0.014
Co 0.23 0.23 0.004 0.002
Cr 0.7 0.7 0.005 0.104
Cu 987 1060 0.025 0.73
Fe 1247 1300 0.02 2.29
Hg 0.8 0.9 0.001 0.0007
K 175473 155000 40 11.0
Mg 20859 20000 0.35 4.84
Mn 8.7 8.3 0.006 0.176
Ni 5.7 5.9 0.013 0.74
Pb 0.7 0.9 0.002 1.719
Rb 6.1 7.1 0.012 0.045
Se 65.7 72.8 0.25 0.031
Sn 0.91 1.05 0.01 0.070
V 0.9 0.8 0.003 0.010
Zn 1086 845 0.025 12.4
All values are given in μg/l.
IDL=instrumental detection limit.
DL=detection limit given as 3*S.D. of blank samples.
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Braun AG (Germany). Spinal tap was performed in a dedicated
patient room with operation theatre cleaning routines. Tubes
were thoroughly rinsed with ultrapure water (Elga, England)
before use. Skin preparation included washing with 4% chlor-
hexidine gluconate in ethanol without phenol red. Liquor was
collected dripping into six 1.8ml polypropylene CryoTubeswith
silicone gasket (Nunc, Denmark), and immediately frozen.
Whole blood was collected into 7.5 ml Lithium-heparin poly-
propylene tubes dedicated for metal analysis (Sarstedt S Monov-
ette system) using a 21G needle (Sarstedt, Germany). After
centrifugation at 3000 rpm for 10 min, plasma aliquots of 1.5 ml
were transferred into fourCryoTubesusingaclearplasticpipette.
Tubes for CSF andplasmawere thoroughly rinsedwith ultrapure
water (Elga) before use. CSF and plasma samples were stored at
−20 °C or below awaiting further metal and protein analyses.
4.3. Fractionation of CSF by SEC-HPLC
A size exclusion column, Superdex 75 (10/300GL, Tricorn,
Sweden), and HPLC system (Hewlett Packard, series 1050,
USA) with quaternary pump, degasser, manual injector (100 μl
loop) and a UV-detector (254 nm) was used for the separation
of proteins in the CSF samples. Pump speed was set at
0.750 ml/min, and 0.02 M Tris-(hydroxylmethyl)-amino-
methane (Tris, 1.08381.0500, Merck) with pH adjusted to 7.4
with 65% HNO3 (1.00441.1000, Merck) was used as the mobile
phase. Fractions (1 min per fraction) were collected in 5 ml
sterile tubes (Falcon, cat. no. 352063) using a fraction collector
(Gilson FC 203B). The CSF samples were injected directly and
untreated into the HPLC equipment. Before the first sample
each day and between each sample the column was washed
with at least 2 volumes of the mobile phase.
The Superdex column was calibrated using proteins with
known molecular weights ranging 6–66 kDa (Table 1); insulin
from bovine pancreas (MW=5.8 kDa, I5500, Sigma), lysozyme
from chicken egg white (MW=14 kDa, 62971, Fluka), trypsin in-
hibitor (MW=24 kDa, T9128, Sigma) and albumin (MW=66 kDa,
A4503, Sigma). To calibrate the column for metallothionein,
freeze dried liverMT (4.8mg,MT-1+MT-2, MW=7 kDa) had been
prepared by one of the authors from rabbit liver (Nordberg et al.,
1972) and dissolved in Tris (0.02 M, 1 ml, pH 7.4) to a final con-
centration of 0.24 mg/ml. This concentration gave a narrow and
defined double peak at 15 min elution time. The double peak is
probably due to a partial overlap of MT-1 and MT-2. Fractions
were subsequently analysed by “off-line” HR-ICP-MS for Cd, Cu,
Fe, Mn and Zn. Reproducibility of the chromatography separa-
tions was checked by comparing repeated runs of the same
sample.
4.4. Sample preparation for trace element analysis
Before trace element analysis samples from the HPLC fractio-
nationswere added 0.1ml conc. HNO3 (Scanpure, Scanlab) and
diluted with 1.65 ml ultrapure water (Elga, England) using a
calibrated pipette. Samples were then decanted into 14 ml
tubes suitable for HR-ICP-MS analysis (Falcon, cat. no. 352059).
Plasma and CSF samples were also analysed for total trace
element content. The samples (1 ml) were digested by adding
concentrated HNO3 (1.0ml, Scanpure, Scanlab, Norway) directly
in 14 ml polypropylene tubes (Falcon) and then digested on a
block heater at 110 °C for 1 h. After digestion, samples were
diluted with ultrapure water (Elga, England) to a final acid
concentration of 0.6 M.
4.5. Trace element analysis
HR-ICP-MS analyses were performed using a Thermo Finnigan
model Element 2 instrument (Germany). The radio frequency
power was set at 1400W. The samples were introduced using a
CETACASX 500 autosamplerwith a peristaltic pump (1ml/min).
The instrument was equipped with a concentric Meinhart
nebulizer connected to a Scott PFA spray chamber, platinum
skimmer and interface cones and a quartz burner with a guard
electrode. Thenebulizer argongas flow ratewasadjusted to give
a stable signalwithmaximumintensity for thenuclides7Li, 115In
and 238U.Methane gaswas used tominimise interferences from
carbon and to provide enhanced sensitivity (Rodushkin et al.,
2005).
The instrument was calibrated using 0.6 M HNO3 solutions
ofmatrixmatchedmultielement standards. Calibration curves
using 5 different concentrations were made using these stan-
dards. To check for instrumental drift, one of these multi-
element standards with known metal concentrations was
analysed for every 10 samples. Certified reference material
(SPS-SW1, SPS-SW-2, Spectrapure, Norway) were analysed at
the beginning and end of each analytical sequence.
4.6. Quality control
For ultra-trace element analysis of clinical samples, controlling
and minimizing all possible sources of contamination is man-
datory (Rodushkin et al., 2004; Rodushkin and Ödman, 2001). To
assess possible contamination during sample preparation, ap-
propriate blank samples of ultrapure water with HNO3 were
preparedusing the sameprocedure as for the samples. All blank
levels obtained were negligible.
The accuracy of the method was verified by analysing the
certified reference material Seronorm Serum Level 1 (Sero,
Norway). Values are given in Table 5 together with detection
limits for the HR-ICP-MS. No reference material for trace
element content of CSF is commercially available.
Acknowledgments
Per M. Roos performed the medical examinations and collected
the samples. Kristin Gellein and Lars Evje performed all the
analytical work. Tore Syversen supervised the laboratory work.
MonicaNordberg purified and suppliedmetallothionein. Kristin
Gellein prepared the first draft of the manuscript. All authors
contributed to the manuscript.
R E F E R E N C E S
Aschner, M., West, A.K., 2005. The role of MT in neurological
disorders. J. Alzheimer's Dis. 8, 139–145.
de la Calle Guntiñas, M.B., Bordin, G., Rodriguez, A.R., 2002.
Identification, characterization and determination of
141B R A I N R E S E A R C H 1 1 7 4 ( 2 0 0 7 ) 1 3 6 – 1 4 2
metal-binding proteins by liquid chromatography. A review.
Anal. Bioanal. Chem. 374, 369–378.
Hozumi, I., Asanuma, M., Yamada, M., Uchida, Y., 2004.
Metallothioneins and neurodegenerative diseases. J. Health
Sci. 50, 323–331.
Hühmer,A.F., Biringer, R.G.,Amato,H., Fonteh,A.N.,Harrington,M.G.,
2006. Protein analysis in human cerebrospinal fluid:
physiological aspects, current progress and future challenges.
Dis. Markers 22, 3–26.
Johansson, N., Basun, H., Blennow, K., Eriksdotter-Jönhagen, M.,
Nordberg, M., 2005. Copper, zinc, iron and protein markers in
cerebrospinal fluid in Alzheimer's disease and normal
cognition. Int. Psychogeriatr. 17, 238.
Lobinski, R., Chassaigne, H., Szpunar, J., 1998. Analysis for
metallothioneins using coupled techniques. Talanta 46,
271–289.
Nordberg, M., 1998. Metallothioneins: historical review and state
of knowledge. Talanta 46, 243–254.
Nordberg, M., Cherian, M.G., 2005. Biological responses of elements.
In: Selinus, O., Alloway, B.J., Centeno, J.A., Finkelman, R.B., Fuge,
R., Lindh, U., Smedley, P. (Eds.), Essentials of Medical Geology.
Elsevier, pp. 179–200.
Nordberg, G.F., Piscator, M., Nordberg, M., 1971. On the distribution
of cadmium in blood. Acta Pharm. Toxicol. 30, 289–295.
Nordberg, G.F., Nordberg, M., Piscator, M., Vesterberg, O., 1972.
Separation of two forms of rabbit metallothionein by
isoelectric focusing. Biochem. J. 126, 491–498.
Prange, A., Schaumlöffel, D., 2002. Hyphenated techniques for the
characterization and quantification of metallothionein
isoforms. Anal. Bioanal. Chem. 373, 441–453.
Richarz, A.-N., Brätter, P., 2002. Speciation analysis of trace
elements in the brains of individuals with Alzheimer's disease
with special emphasis on metallothioneins. Anal. Bioanal.
Chem. 372, 412–417.
Rodushkin, I., Ödman, F., 2001. Assessment of the contamination
from devices used for sampling and storage of whole blood
and serum for element analysis. J. Trace Elem. Med. Biol. 15,
40–45.
Rodushkin, I., Engström, E., Stenberg, A., Baxter, D.C., 2004.
Determination of low-abundance elements at ultra-trace levels
in urine and serum by inductively coupled plasma sector field
mass spectrometry. Anal. Bioanal. Chem. 380, 247–257.
Rodushkin, I., Nordlund, P., Engström, E., Baxter, D.C., 2005.
Improved multi-elemental analyses by inductively coupled
plasma-sector field mass spectrometry through methane
addition to the plasma. J. Anal. At. Spectrom. 20, 1250–1255.
Roos, P., Vesterberg, O., Nordberg, M., 2006. Metals in motor
neuron diseases. Exp. Biol. Med. 231, 1481–1487.
Sickmann, A., Dormeyer, W., Wortelkamp, S., Woitalla, D., Kuhn,
W., Meyer, H.E., 2002. Towards a high resolution separation of
human cerebrospinal fluid. J. Chromatogr., B 771, 167–196.
Smith, Q.R., Rabin, O., Chikhale, E.G., 1997. Delivery of metals to
brain and the role of the blood–brain barrier. In: Connor, J.R.
(Ed.), Metals and Oxidative Damage in Neurological Disorders.
Plenum Press, pp. 113–130.
Stryer, L., 1997. Protein folding and design, Biochemistry, 4th ed.
W.H. Freeman and Company, New York, pp. 417–440.
Wang, J., Dreessen, D., Wiederin, D.R., Houk, R.S., 2001. Measurement
of trace elements in proteins extracted from liver by size
exclusion chromatography-inductively coupled plasma-mass
spectrometry with a magnetic sector mass spectrometer. Anal.
Biochem. 288, 89–96.
Yuan, X., Desiderio, D.M., 2005. Proteomics analysis of human
cerebrospinal fluid. J. Chromatogr., B 815, 179–189.
142 B R A I N R E S E A R C H 1 1 7 4 ( 2 0 0 7 ) 1 3 6 – 1 4 2






Paper ȱȱȱ
 
 
 
 
 
 
 
 
 
Paper III 
 
 Is not included due to copyright 
 






Paper ȱV

Trace elements in cerebrospinal fluid and blood from patients with a rare
progressive central and peripheral demyelinating disease
Kristin Gellein a,⁎, Jon H. Skogholt b, Jan Aaseth c, Gunnar B. Thoresen d, Syverin Lierhagen a,
Eiliv Steinnes a, Tore Syversen e, Trond Peder Flaten a
a Department of Chemistry, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway
b Municipality of Sør-Odal, NO-2100 Skarnes, Norway
c Sykehuset Innlandet Kongsvinger, NO-2212 Kongsvinger, Norway
d Department of Neurology, Sykehuset Innlandet Elverum, NO-2418 Elverum, Norway
e Department of Neuroscience, Norwegian University of Science and Technology, NO-7489 Trondheim, Norway
Received 1 June 2007; received in revised form 28 August 2007; accepted 30 August 2007
Available online 27 September 2007
Abstract
A hereditary neurological disease in a family in Norway has been reported recently. The disease, which we refer to as Skogholt's disease,
is a demyelinating disorder of both the central and the peripheral nervous system with adult onset. We investigated whether changes in trace
element concentrations could play a role in Skogholt's disease. Using high resolution inductively coupled plasma mass spectrometry, we
determined 31 elements in cerebrospinal fluid (CSF), blood plasma and whole blood from these patients, multiple sclerosis patients and a
control group. More than threefold increased levels of Cu and Fe, and a twofold increase in Zn were found in the CSF of Skogholt patients
compared to controls. Several other significant differences in trace element levels were also found. The increased levels of Cu and Fe in CSF
may indicate an active role of these metals in the pathogenesis of Skogholt's disease. Apparently, these metal ions are transferred into the
CSF through their protein chelation, as raised protein levels were also seen. We suggest that redistribution of metals from transport proteins
into vulnerable sites in the central (and peripheral) nervous system may initiate critical lesions.
© 2007 Elsevier B.V. All rights reserved.
Keywords: Copper; Iron; Zinc; HR-ICP-MS; Multiple sclerosis; CSF proteins; Albumin; Skogholt's disease
1. Introduction
One of us (J.H.S.) recently discovered a family in Norway
with a neurological disease, here referred to as Skogholt's
disease, which apparently has not been found elsewhere. The
disease has so far been diagnosed in 3 generations and has
been thoroughly described by Hagen et al. [1]. It is a demy-
elinating disorder affecting both the central and the peripheral
nervous system and it is different from previously described
hereditary demyelinating disorders [1,2]. The symptom onset
varies from before 30 to after 50 years of age, and the disease
is uniformly gradually progressive. The symptoms are
typically a gradually developing distal sensory loss, distal
atrophy of extremity muscles or weakness of muscles in all
extremities, unsteady gait, dysarthria, cognitive slowness,
and memory impairment. Some patients have recurrent
episodes of cerebral ischemia. The previously studied
patients had increased cerebrospinal fluid protein levels [1].
Causes and mechanisms of this disease are unknown.
Considerable evidence implicates transition metals and
other trace elements in the pathogenesis and/or aetiology of
several neurodegenerative diseases [3,4]. Manganese has
long been known as a neurotoxic trace element [5], as over-
exposure can cause manganism, a neurological syndrome
that resembles Parkinson's disease [3]. Furthermore,
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considerable evidence suggests a role of the transition metals
Cu and Fe in the pathogenesis of various neurodegenerative
diseases, either by overexposure or deficit, and/or by dis-
turbed inter- or intracellular metal trafficking [6]. Changes
in the expression of metal-binding proteins have also been
observed [7].
Skogholt's disease is an inherited disorder [1,2]. Several
inherited neurological disorders in which metals are involved
in the pathogenesis have been described [8–11]. In both
Wilson's disease [8] and Menkes' disease [9], copper trans-
port is disrupted, and demyelination is observed in the af-
fected cerebral loci of patients with Wilson's disease [12].
The primary aim of the present study was to investigate
whether changes in trace element concentrations could play a
role in Skogholt's disease. Through common disease mech-
anisms, the results from this study may also be relevant for
the pathogenesis of other demyelinating disorders such as
multiple sclerosis (MS). Using HR-ICP-MS (high resolution
inductively coupled plasma mass spectrometry) [13], we
determined 31 elements in CSF, blood plasma and whole
blood from these patients, MS patients and a control group.
We found substantially raised Cu and Fe levels in CSF of
Skogholt patients, which might suggest a role of these metals
in the pathogenesis of the disease.
2. Materials and methods
2.1. Subjects
All study participants live in the county of Hedmark in the
eastern inland part of Norway, their clinical characteristics
are given in Table 1. Ten patients (6 men and 4 women)
diagnosed with Skogholt's disease were included in the
study. These were all the patients that were physically ca-
pable of travel and thus available for sampling of CSF and
blood. Nine subjects diagnosed with multiple sclerosis were
also included in the study. The control group comprised 13
individuals (5 males and 8 females) with no known neu-
rological disease.
Table 1 lists the diagnoses, age and sex of all partic-
ipants, together with information about daily consumption
of coffee (tea was rarely consumed), smoking habits,
physical activity and education collected from ques-
tionnaires filled out by the subjects during the diagnostic
assessment. There is a good match in gender between the
Skogholt and control group, but the MS group consists of
90% women. There were higher percentages of smokers
both in the Skogholt group (60%) and in the MS group
(78%) than in the control group (46%).
Written consent was obtained from each participant and
the project has been approved by the Regional Committee
for Medical Research Ethics in Norway (Region East, ref.
no. 556-04224). Subjects were interviewed using a stan-
dardized form as to their life style, dietary habits and medical
history. None of the participants in the study have had known
occupational exposure to trace elements.
2.2. Sample collection and treatment
Samples were collected from patients in connection with
diagnostic assessment at Sykehuset Innlandet Elverum, De-
partment of Neurology. Maximum care was taken to avoid
trace element contamination of the samples. The samples for
trace element analysis were always collected after the sam-
ples for clinical–chemical analysis, to flush out the needles
and tubing. The cerebrospinal fluid was obtained by lumbar
puncture performed in the lateral recumbent position with
Table 1
Clinical characteristics of patients
Diagnosis Age Sex Smoker Coffee
(L/day)
Activity Education
Skogholt group
Skogholt's disease 34 m Y 0.3 Y U
Skogholt's disease 40 m Y 0.7 L E
Skogholt's disease 32 m Y N1 N H
Skogholt's disease 49 f Y 1.0 L E
Skogholt's disease 28 m Y N1 N E
Skogholt's disease 44 f N 0.3 N H
Skogholt's disease 52 f Y 1.0 Y E
Skogholt's disease 55 f N 0.4 Y E
Skogholt's disease 57 m N 0.4 L E
Skogholt's disease 67 m N 0.5 N E
Mean age 45.8
SEM (age) 3.9
MS group
Multiple sclerosis 60 f Y 1.0 L E
Multiple sclerosis 50 f Y 1.0 Y E
Multiple sclerosis 36 m Y N1 N H
Multiple sclerosis 42 f Y 0.4 Y E
Multiple sclerosis 37 f N 0 N H
Multiple sclerosis 37 f Y 0.5 Y H
Multiple sclerosis 46 f N 0.3 Y H
Multiple sclerosis 37 f Y 0.5 L E
Multiple sclerosis 50 f Y 1.0 Y E
Mean age 43.9
SEM (age) 2.8
Controls
Myalgia 48 f N 0.6 N E
Myelopathy 56 f Y 0 Y E
Myelopathy 50 f Y N1 Y E
No findings 38 f N 0 Y C
No findings 36 m N 0.5 L E
No findings 34 m Y 0.15 N E
Paresthesia 57 m N 0.2 N H
Polyneuropathy 58 m N 0.5 L E
Cervical stenosis 60 f Y 0.4 L E
Bell's palsy 48 f N 0.15 Y U
Herpes zoster 78 f N 0.1 Y E
Cerebral infarcion 48 m Y 1.0 N E
Migraine 31 f Y 0.5 L E
Mean age 49.4
SEM (age) 3.6
f=female, m=male.
Smoker: Smoked regularly during the last 2 years.
Activity: physical activity classified as Y=yes, N=no, L= little.
Education: E=elementary school, H=high school, C=college, U=university.
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a stainless steel needle (0.7×88 mm, Spinocan, B. Braun
Melsungen). The CSF ran trough polyethylene tubing
(Mediplast AB) into a polypropylene tube (8 mL, Sarstedt).
The blood samples were obtained using a stainless steel needle
(Becton Dickinson) and collected in tubes specially designed
for trace element analysis (7 mLVacutainer, sodium heparin,
Becton Dickinson). All samples were stored at −20 °C until
analysis.
2.3. Clinical–chemical analyses
All clinical–chemical analyses were performed at Syke-
huset Innlandet Kongsvinger. Blood samples were analysed
for haematological profile, transferrin, ceruloplasmin, F-T4,
F-T3, TSH, cholesterol, triglycerides, HDL, protein, albumin
and by electrophoresis for total protein, albumin and IgG.
Protein analysis and electrophoresis were performed on CSF.
Prior to trace element analysis, all samples were digested
by adding concentrated HNO3 (Scanpure) directly in poly-
propylene tubes (Falcon, 14 mL) and then digesting on a
block heater (110 °C, 1 h). For whole blood 1 mL HNO3 was
added to 1 mL of sample, for plasma 0.5 mL HNO3 was
added to 1 mL of sample and for CSF 0.5 mL HNO3 was
added to 0.5 mL of sample. After digestion, samples were
diluted with ultrapure water (Elga) to achieve a final acid
concentration of 0.6 M.
HR-ICP-MS analyses were performed using a Thermo
Finnigan model Element 2 instrument (Bremen, Germany).
The radio frequency power was set to 1250 W. The samples
were introduced using a CETAC ASX 500 autosampler with
a peristaltic pump (1 mL/min). The instrument was equipped
with a concentric Meinhart nebulizer connected to a Scott
PFA spray chamber, platinum skimmer and interface cones
and a quartz burner with a guard electrode. The nebulizer
argon gas flow rate was adjusted to give a stable signal with
maximum intensity for the nuclides 7Li, 115In and 238U.
Methane gas was used in the analysis of CSF to minimise
interferences from carbon and to provide enhanced sensitiv-
ity [14].
The instrument was calibrated using 0.6 M HNO3 so-
lutions of matrix matched multielement standards. A cal-
ibration curve using 5 different concentrations was made
from these standards. To check for instrumental drift, one of
these multielement standards with known metal concentra-
tions was analysed for every 10 samples. Certified reference
material was analysed at the beginning and end of each
analytical sequence.
2.4. Quality control
For ultra-trace element analysis of clinical samples,
controlling and minimising all possible sources of contam-
ination is vital [15]. The potential contamination risk asso-
ciated with devices routinely used in hospitals and clinical
laboratories for sampling and storage of whole blood and
serum is usually quite low [16]. To assess possible con-
tamination during sample preparation, blank samples of
ultrapure water were prepared using the same procedure as
for the samples. All blank levels obtained were negligible.
The accuracy of the method was verified by repeated
analyses of the certified reference materials Seronorm whole
blood and Seronorm Serum Level 1 and Level 2 (Sero). The
concentrations found were within 85–115% of the certified
values. The precision of the method was checked by analysing
Table 2
Results from the clinical chemical analyses
Skogholt (n=10) MS (n=9) Controls (n=13)
Unit Mean SEM Mean SEM Mean SEM
Serum Albumin g/L 43.5 0.9 45.0 0.7 44.1 0.6
Protein g/L 71.6 1.1 74.1 0.9 73.2 1.2
Iron μmol/L 15.2 2.3 18.9 3.2 18.8 1.8
Transferrin g/L 2.7 0.1 2.8 0.1 2.6 0.1
Trf. Sat. % 21.9 3.1 26.7 4.0 29.2 3.2
Ferritin μg/L 83.5 19.8 72.0 18.7 155 35.3
F-T4 pmol/L 15.0 0.6 12.4 0.5 12.8 0.6
F-T3 pmol/L 4.3 0.1 4.1 0.1 3.8 0.1
TSH mU/L 1.3 0.3 1.3 0.1 1.9 0.3
Cholesterol mmol/L 6.1 0.4 6.0 0.4 5.9 0.4
TRiglyseride mmol/L 3.0 0.6 1.2 0.2 2.0 0.3
HDL-cholesterol mmol/L 1.2 0.0 1.5 0.1 1.4 0.1
Serum electrophoresis Total protein g/L 72 1.1 74 0.9 73 1.2
Albumin g/L 44 0.9 45 0.7 44 0.6
IgG g/L 9.7 0.6 10.7 0.5 10.9 0.8
CSF electrophoresis Total protein mg/L 1218 112 319 20 360 45
Albumin mg/L 694 66 184 14 225 31
IgG mg/L 117 27 50 8 33 6
Mean denotes the arithmetic mean and SEM is the standard error of the mean.
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four separate preparations of the same samples and it was
better than 15% relative standard deviation for all elements.
In conclusion, the precision and accuracy of the HR-ICP-
MS method was acceptable for all three types of body fluid.
The concentrations of trace elements found in this study are
among the lowest reported in human CSF [17–21], indicating
that contamination of the samples has not been a major
problem. Also for whole blood and plasma our values are in
the lower range of values reported earlier [17–19,22–25].
2.5. Statistical evaluation
SPSS was used for statistical evaluation. Differences be-
tween the groups were tested using one-way analysis of
variance (ANOVA) with post hoc multiple comparisons. At
pb0.05 differences were considered significant.
3. Results
Table 2 shows that the level of serum ferritin is markedly
decreased (about 50%) in both Skogholt and MS patients.
All patients with Skogholt's disease have highly increased
level of protein in the CSF, with values ranging between 0.80
and 2.24 g/L, which is almost 4 times higher than in the MS
patients and controls. Protein levels this high are quite rare
and may in fact be valuable as a diagnostic tool for this
disease.
Table 3 shows the concentrations of the 31 elements in
blood plasma, whole blood and CSF. Selected results for CSF
are given in Figs. 1–6, both in μg/L and in μg/mg protein.
3.1. Blood
In whole blood, an increased level of Mn was found in
MS patients as well as in Skogholt patients. Significantly
increased levels of Co (30%), P (10%), Rb (30%), S (7%)
and Th (85%) were also observed for Skogholt patients
compared to controls. The level of Ag was higher for MS
patients in both blood plasma and whole blood, although the
difference was not significant in whole blood. A slightly
increased level of Rb was found in both blood plasma and
whole blood in the Skogholt patients. The level of Mo was
lower in both Skogholt patients and MS patients compared to
the control group.
Fig. 1. Cu concentrations inCSF (μg/L). Boxes represent 75th (upper) and 25th
(lower) percentiles, while the horizontal line indicates the median value.
Vertical bars show the upper and lower extremes of the range (95th and 5th
percentiles). A shows concentrations in μg/L, B in μg/mg protein.
Fig. 2. Fe concentrations in CSF (μg/L). Boxes represent 75th (upper) and
25th (lower) percentiles, while the horizontal line indicates the median
value. Vertical bars show the upper and lower extremes of the range (95th
and 5th percentiles). A shows concentrations in μg/L, B in μg/mg protein.
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3.2. CSF
The most striking finding in this study was a more than
threefold increase in the concentrations of Cu and Fe, and a
twofold increase in Zn in the CSF of Skogholt patients
relative to controls. A parallel increase in Se and S was also
observed. The levels of the toxic metals Cd, Hg and Tl were
significantly lower in Skogholt patients compared to
controls.
4. Discussion
The main finding in the present study is the highly
increased levels of Cu, Fe and Zn in CSF from patients with
Skogholt's disease. Whether these increased metal levels are
a cause of effect of the disease is impossible to state at
present, however as this finding is not reflected in blood it
seems probable that the increased levels in CSF are not
caused by increased environmental exposure.
One of the characteristic features of Skogholt's disease is
a highly increased protein level in CSF, which was
confirmed in this study. The increased protein level could
be caused by leakage across the blood–brain barrier. Cu, Fe
and Zn are known to be chelated to proteins. Thus, it seems
likely that the increased trace element levels found in CSF
occur as a leakage of protein chelates from blood to CSF. We
were not able to find any apparent correlations between CSF
concentrations of protein, Cu, Fe or Zn, and duration of the
disease or the age of the patients. This suggests that a leakage
of metal carrying proteins into the CSF may be an early pre-
symptomatic event that could contribute to the disease
process, rather than being a secondary consequence of the
disease progression.
There were decreased levels of Hg and Cd compared to
controls in CSF from Skogholt patients. These metals appear
to be more tightly bound to high molecular weight
selenoproteins than to albumin in the circulation and may
thus avoid the diffusion into the CSF [26].
The only finding common to both the Skogholt and MS
patients was a 30% increased level of Mn in whole blood. A
limited number of studies have been published on the
possible role of trace elements in MS [20,27–35]. Melø et al.
[20] found increased Cu levels and decreased Mn in CSF in
MS patients compared to controls, and no differences were
Fig. 4. Mn concentrations in CSF (μg/L). Boxes represent 75th (upper) and
25th (lower) percentiles, while the horizontal line indicates the median
value. Vertical bars show the upper and lower extremes of the range (95th
and 5th percentiles). A shows concentrations in μg/L, B in μg/mg protein.
Fig. 3. Zn concentrations in CSF (μg/L). Boxes represent 75th (upper) and
25th (lower) percentiles, while the horizontal line indicates the median
value. Vertical bars show the upper and lower extremes of the range (95th
and 5th percentiles). A shows concentrations in μg/L, B in μg/mg protein.
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found for Zn. Normal values for Fe, K, Na, Rb, Ca and Mg
have been reported in blood or CSF [30–34].
The substantial alterations in metal homeostasis observed
in the Skogholt group might result in an increased level of
free radicals [4,36,37]. A large body of evidence implicates
crucial roles of oxidative stress in the pathogenesis of several
neurodegenerative disorders [37,38], including multiple
sclerosis [39]. The nervous system and in particular the
myelin sheath seems to be more susceptible to oxidative
damage than other organs, partly due to its high metabolic
activities and rather marginal antioxidant defence systems
and a relatively high content of vulnerable fatty constituents
[36]. The progressive myelin destruction that characterizes
Skogholt's disease and MS may be accelerated by oxidative
stress.
Normally, most metals circulate in blood bound to
proteins rather than as free ions [40]. Cu is bound to the
specific Cu-transporter ceruloplasmin (90%) and to albumin
(6%). In the same way Fe is bound in blood to transferrin
(N99%), while zinc is primarily bound to albumin (65%) and
to a high molecular weight α-macroglobulin (32%) [40]. Mn
is bound to transmanganin and albumin [41]. CSF resembles
an ultrafiltrate of blood plasma [42,43]. Small amounts of
plasma proteins enter the CSF at the choroid plexus, but also
through the circulation of CSF. Two major barriers, the
blood–brain barrier and the blood-CSF barrier define the
major entry and exit routes of components into the CSF from
the circulation [43]. Similarly, a tight barrier also protects the
peripheral nervous system. Thus, the physiological protein
concentration in CSF is only about 0.5% of that in the blood
plasma. However, the protein pattern is very different.
Proteins are transferred from plasma to CSF by diffusion,
and the barrier is more easily traversed by small proteins than
by larger, so the fraction of smaller proteins are larger in CSF
compared to blood [43].
The results from electrophoresis of CSF from Skogholt
patients (Table 2) show that more than 50% of the total
protein content is albumin, and about 10% is IgG. Since
albumin is exclusively synthesized in the liver, an increased
albumin concentration in CSF strongly indicates increased
blood-CSF barrier permeability [43]. Albumin and IgG are
proteins of rather low molecular weight, which penetrate the
barrier more easily by diffusion than larger proteins. Both Cu
and Zn levels were elevated in the CSF of Skogholt patients
compared to controls (Table 3). Both metals have a high
Fig. 5. Se concentrations in CSF (μg/L). Boxes represent 75th (upper) and
25th (lower) percentiles, while the horizontal line indicates the median
value. Vertical bars show the upper and lower extremes of the range (95th
and 5th percentiles). A shows concentrations in μg/L, B in μg/mg protein.
Fig. 6. S concentrations in CSF (μg/L). Boxes represent 75th (upper) and
25th (lower) percentiles, while the horizontal line indicates the median
value. Vertical bars show the upper and lower extremes of the range (95th
and 5th percentiles). A shows concentrations in μg/L, B in μg/mg protein.
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affinity to albumin, which is almost comparably elevated in
the CSF of the Skogholt group (Table 2). Therefore, it seems
probable that Cu and Zn in CSF are transferred across the
blood–brain barrier as albumin chelates. There were strong
correlations between the protein level and the concentration
of S and Se in CSF (Figs. 5 and 6). Cu and Zn are known to
bind strongly to both selenium- and sulphur-containing
ligands, which probably explain the strong correlations with
S and Se for both Cu and Zn in the CSF (Fig. 7). While S and
Se are incorporated into albumin as amino acids, Cu and Zn
are reversibly chelated by the binding groups.
Metal ions carried by albumin or transferrin are readily
exchangeable, as these proteins are the physiological
transporters of metal ions to the tissues. When such metal-
protein complexes are transported to target ligands with a
higher affinity to the metals, a fraction of the metals may
escape from their protein carriers and be redistributed to
vulnerable sites. Vulnerable sites within the CNS may
include myelin, and there are indications that metals may
exert or aggravate toxic effects on myelin [44,45]. Toxic
effects are of course more likely with long-term overexpo-
sure, as is the case for Cu, Fe and Zn in the CSF of the
Skogholt patients.
All available evidence points to Skogholt's disease being
hereditary [2]. Based on the results from the present study we
hypothesize that a blood–brain barrier dysfunction is an
early and presumably primary inherited defect, which causes
the observed increases in metal concentrations. Whether the
observed myelin degradation process might be causally
related to the resulting long-term metal exposure deserves
further exploration.
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Abstract
To assess whether trace elements are involved in Parkinson’s disease (PD) we have 
conducted a prospective study where 19 trace elements have been determined in serum 
collected from 33 patients before they were diagnosed with the disease, and 99 controls. 
As a follow-up, serum from 19 of the same patients collected 4-12 years after they were 
diagnosed with PD has been analysed. In the prospective part of the study, the only 
significant difference was a slightly lower content of Hg in the patient group than in the 
controls. In the follow-up, significantly higher levels of Hg, Ni, and Y, and lower levels 
of Ca, Fe, Mg, Mn, Rb and Se were found in the serum samples collected after the 
patients were diagnosed with PD compared with pre-diagnostic levels. 
Section:
Disease-Related Neuroscience 
Keywords: 
Parkinson’s disease; trace elements; epidemiology; prospective case-control study
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1. Introduction 
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects 
approximately 1% of adults older than 60 years. It is characterized by a progressive loss 
of dopaminergic neurons in the substantia nigra that is accompanied by a reduction in 
the synthesis of the neurotransmitter dopamine (Samii et al., 2004). The cause of the 
disease is still unknown but it seems likely that a number of aetiological factors are 
involved including ageing, genetic susceptibility, environmental exposure and lifestyle 
(Powers et al., 2003; de Lau and Breteler, 2006). In epidemiological studies, several 
factors have been reported to be associated with PD including age, exposure to toxicants 
(metals, pesticides and other neurotoxic substances), diet (sugar, vitamins, animal fats 
etc.), farming, non-smoking and family history of PD (Gorell et al., 2004). Cigarette 
smoking has consistently been found to be inversely associated with the risk of 
developing PD (Gorell et al., 1999). The risk of PD has also been reported to be 
inversely related to caffeine intake, both from coffee and non-coffee sources (Samii et 
al., 2004). 
Transition metals such as Fe, Zn, Cu, and Mn are essential in many important biological 
reactions such as synthesis of DNA, RNA and proteins, and as cofactors of numerous 
enzymes. However, apart from Zn, these metals are also redox-active and have the 
ability to promote free radical formation that leads to oxidative stress. Considerable 
evidence implicates crucial roles of oxidative stress in the pathogenesis of major 
neurodegenerative disorders (Halliwell, 2006). The redox-active transition metals seem 
to play important roles in mediating the processes leading to oxidative stress, and thus 
may be involved in the neuropathology of disorders such as PD (Campbell et al., 2001). 
A limited number of studies have addressed changes in serum trace elements in PD 
patients (Forte et al., 2004, 2005; Bocca et al., 2004; Hegde et al., 2004). To our 
knowledge, there are no data on trace element concentrations in body fluids of PD 
patients where the samples have been collected before they were diagnosed. Therefore, 
we conducted the present prospective study, utilizing serum samples collected in 1995-
3
1997 as part of the population-based second Nord-Trøndelag health study (HUNT 2) 
(Holmen et al., 2003), where about 75% of the population in Nord-Trøndelag county 
participated. 
Changes in trace elements in PD patients could be a cause or a consequence of the 
disease. To address this issue, we obtained a second blood sample from 19 of the 33 PD 
patients included in the prospective study. Thus, these samples were collected 4-12 
years after the patient was diagnosed with PD, and 10-12 years after the first samples 
were collected. Using HR-ICP-MS (high resolution inductively coupled plasma mass 
spectrometry) we have determined 19 elements in the serum samples. 
2. Results
The characteristics of the PD patients are shown in Table 1. The table also shows for 
which patients a second blood sample was collected. Table 2 shows analytical detection 
limits and the results from analysis of certified reference sera. 
Table 3 shows the trace element concentrations in serum from controls (n=99) and PD 
patients (n=33) before they were diagnosed with the disease. Results from the multiple 
conditional logistic regression analysis are given as odds ratios with 95% confidence 
intervals and p-values. In Table 4, the results from the follow-up are shown. 
In the prospective part of the study (Table 3), the only significant difference was a 
slightly lower content of Hg in the patient group than in the controls. When trace 
element levels in patients from before and after they were diagnosed were compared 
(Table 4), significantly higher levels of Hg, Ni, and Y, and lower levels of Ca, Fe, Mn, 
Mg, Rb, and Se were found in the serum samples collected after the patients were 
diagnosed with PD. There were no apparent relations between trace element 
concentrations and duration of the disease (results not shown). 
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3. Discussion 
The causes of PD are still largely unknown, but environmental factors seem to play a 
role in most cases, probably in interaction with susceptibility genes (de Lau and Breteler, 
2006). Trace elements, and redox-active transition metals in particular, have been 
implicated in the pathogenesis of PD (Sayre et al., 1999). A large body of evidence 
implicates crucial roles of oxidative stress in the development of PD and other 
neurological diseases (Halliwell, 2006). Iron has more than other transition metals been 
implicated to undergo redox transitions leading to the generation of free radicals 
(Campbell et al., 2001). Increased levels of iron and oxidative stress have been found in 
different brain areas of PD patients, especially in the substantia nigra (Riederer et al., 
1989; Gerlach et al., 1994). In this study, no difference in the level of serum Fe was 
found in the PD group before they were diagnosed compared to controls. However, the 
level of Fe was significantly decreased after diagnosis compared to prediagnostic levels. 
Decreased levels of Fe in serum of PD patients were reported in studies by Forte et al. 
(2005) and Hegde et al. (2004). 
Copper has a functional role in many enzymes that require redox-reactions and an 
imbalance in the Cu homeostasis might lead to increased free radical production 
(Gaggelli et al., 2006). No significant differences were found for Cu (Tables 3 and 4). 
Forte et al. (2005) found a decrease in serum Cu in PD patients, while Hegde et al. 
(2004) found increased Cu levels in serum from patients with severe PD compared with 
controls.
Mn has long been considered as a possible contributor to PD because of its ability to 
cause manganism, a neurological disease with clinical signs similar to those displayed 
by subjects with PD (Calne et al., 1994). A significantly lower level of Mn was found in 
PD patients after diagnosis compared to prediagnostic levels. In two separate studies no 
difference in serum manganese was observed between PD patients and controls 
(Jiménez-Jiménez et al., 1995; Bocca et al., 2004). 
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The neurotoxic properties of Hg are well documented. Hg has the capability to damage 
neurons via a number of mechanisms (Aschner and Aschner, 1990). Bocca et al. (2004) 
reported a reduction of Hg in serum of PD patients compared to controls. In the present 
study a decreased level of Hg was associated with a decreased risk of Parkinsons 
disease according to the conditional logistic regression analysis (OR=0.69, p=0.03, 
Table 3). The level of Hg was however significantly higher in PD patients compared to 
prediagnostic levels (Table 4).
Ca and Mg are essential elements that are found in high amounts in serum. Little has 
been reported on the role of Ca and Mg in PD or related disorders, but a low intake of 
Ca and Mg has been implicated in parkinsonism-dementia on Guam (Garruto, 1991). 
Slightly but significantly lower levels of both elements were found in PD patients 
compared to prediagnostic levels. A lower level of Ca in serum of PD patients was also 
reported by Pino et al. (2005), while Forte et al. (2004) found a higher level of Ca. The 
same controversy also exists for Mg where Forte et al. (2004) found a lower level of Mg 
in serum from PD patients, while Hegde et al. (2004) reported a higher level. 
Selenium is a well-known antioxidant, and there are some indications from animal 
models that Se may be protective in PD (Schweizer et al., 2004). However, we found no 
difference in serum Se levels between prediagnostic PD cases and controls (Table 3), 
but an average decrease of 34% in the PD cases between the two sampling times (Table 
4). This may be at least partly related to the diseases process, although it should be 
noted that a slight decrease in serum Se with age has been reported in some studies 
(Versieck and Cornelis, 1989). 
Increased levels were found in the PD patients compared to prediagnostic levels for Ni 
and Y, and a lower level was found for Rb (Table 4). We are not aware that any of these 
elements have been discussed as potential factors in the aetiology or pathogenesis of PD. 
In summary, significant changes were found for several trace elements in serum 
collected from PD patients before they were diagnosed compared with levels in serum 
collected several years after they were diagnosed. However, when prediagnostic PD 
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patients were compared with controls no significant differences were found. Although it 
is possible that the levels of some trace elements in blood may change with age 
(Versieck and Cornelis, 1989), the observed differences may indicate that the illness 
could introduce changes in trace element homeostasis rather than the trace elements 
being a causative factor in PD. Such changes can be the result of biochemical 
characteristics of the illness itself or changes in environmental conditions (e.g. diet and 
physical activity) associated with the illness. There are no indications of significant 
changes in trace element exposure in the population of Nord-Trøndelag during the time 
between the first and the last collection of samples. However, as our study has relatively 
few patients, similar studies in other populations are warranted. 
4. Experimental procedure 
4.1. Subjects
All participants lived in the county of Nord-Trøndelag in the middle part of Norway at 
the time of sample collection in the HUNT 2 health survey in 1995-1997. Thirty-three 
patients (16 men and 17 women) diagnosed with idiopathic Parkinson’s disease (PD) 
after 1995 were included in the study (Table 1). All PD patients were recruited among 
the outpatients attended in the neurology departments of two hospitals (Levanger 
Hospital and Namsos Hospital) and at one neurologist in private practice (Neurologist 
Duraj). All PD patients were assessed by neurologists and met the commonly accepted 
“UK Parkinson’s Disease Society Brain Bank” diagnostic criteria for PD (Hughes et al., 
1992). The control group comprised of 99 age (year of birth) and gender matched 
individuals (48 men and 51 women) with no known neurological disease. All subjects 
were thoroughly interviewed through the HUNT study in order to obtain detailed 
information about dietary habits, lifestyle and personal medical history, and we had 
access to all of this data. Written consent was obtained from each participant and the 
project has been approved by the Regional Committee for Medical Research Ethics. 
4.2. Sample collection and treatment
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A 7.5 ml blood sample was drawn from each participant. Serum was prepared by 
centrifuging at the screening site (3000 rpm, 10 min) and the centrifuged solution was 
immediately placed in a refrigerator. The samples were stored at -70 ºC until 2004 when 
aliquots of 300 μl were transferred to polypropylene tubes (14 ml, Falcon, USA) and 
frozen at -20 ºC until preparation for trace element analysis. 
In 2007, we obtained a second blood sample from 19 of the 33 PD patients sampled in 
1995-97. All samples were collected by the same procedure. Aliquots of 500 μl of 
serum were transferred to polypropylene tubes before samples were frozen at -20 ºC 
awaiting sample preparation. 
Prior to trace element analysis, all samples were added concentrated HNO3 (1:1 v/v) 
(Scanpure, Chem Scan, Norway) directly in the polypropylene tubes and digested on a 
block heater (110 ºC, 1 hour). After digestion, samples were diluted (1:24) with 
ultrapure water (Q-option, Elga, England) to achieve a final acid concentration of 0.6 M. 
4.3. Trace element analysis
HR-ICP-MS analyses were performed using a Thermo Finnigan model Element 2 
instrument (Bremen, Germany). The radio frequency power was set to 1400 W. The 
samples were introduced using a CETAC ASX 500 autosampler with a peristaltic pump 
(1 ml/min). The instrument was equipped with a concentric PFA-ST nebulizer 
connected to a Scott PFA spray chamber, platinum sample and skimmer cones and a 
demountable torch of quartz with a guard electrode. The instrument was calibrated by 
external calibration, using 0.6 M HNO3 solutions of multielement standards, matrix 
matched by adding 100 mg/l Na. A calibration curve using five different concentrations 
was made from these standards. To correct for instrumental drift, one of these 
multielement standards with known metal concentrations was analysed for every 10 
samples. All corrections were done manually after analysis. An aqueous certified 
reference material containing 66 elements (SPS-SW-2, Spectrapure Standards, Norway) 
was analysed as a quality control of the calibration of the instrument. To minimise 
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interferences, elements were determined in different resolutions; low resolution (m/ m
= 400) (Hg, Pb, Tl, U, Y), medium resolution (5500) (Ca, Co, Cr, Cu, Fe, Mg, Mn, Mo, 
Ni, Rb, Sr, Zn) and high resolution (11,000) (As, Se). 
4.4. Analytical quality control
The accuracy of the method was verified by repeated analysis of the certified reference 
materials Seronorm Level 1 and Level 2 (Sero, Norway). The concentrations found 
(Table 2) were within 90-115% of the certified values, except for Mo (81%), Y (83%) 
and Zn (124%) in Seronorm Level 1. The range of the analytical results (Table 2) is a 
measure of the precicion of the method. To assess possible contamination during sample 
preparation, blank samples of ultrapure water added HNO3 (1:1) were prepared using 
the same procedure as for the samples. All blank levels obtained were negligible. Since 
no specific precautions to prevent trace element contamination were taken when the 
samples were collected in 1995-1997, we performed a leaching test of the cannulas and 
vacutainer tubes that were used. There were no indications of significant problems with 
contamination from either. 
4.5. Data analysis
Using data from the first, prospective part of the study, we calculated the odds ratios 
(OR) for PD in relation to serum levels of trace elements using conditional logistic 
regression. In this analysis, we adjusted for the potential confounding effect of age, sex, 
coffee intake (cups per day), education (high school, college, university) and smoking 
habits (smoker, previous smoker, non-smoker). The precision of the estimated 
associations was indicated by 95% confidence intervals (CI). 
In the second part of the study, a paired sample t-test was used to compare the levels of 
trace elements in serum samples from the same 19 patients collected prior to PD 
diagnosis with samples collected after diagnosis. 
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Table 1. Characteristics of Parkinson’s disease patients. Initial samples were collected 
during 1995-97. The second samples were collected in 2007. 
Born Gender Diagnosis Second sample
1 1958 M 2001 +
2 1932 W 2000 +
3 1937 W 2001 +
4 1931 W 2001 +
5 1932 M 1998
6 1936 M 1997 +
7 1930 W 1998
8 1945 M 1997 +
9 1924 M 2002 +
10 1927 W 2000 +
11 1931 W 2001
12 1945 W 1998 +
13 1938 W 2001 +
14 1928 W 2001 +
15 1937 M 2003 +
16 1952 M 1998 +
17 1952 M 2000
18 1928 W 1996
19 1928 M 1998 +
20 1919 M 2000
21 1929 M 1998
22 1936 W 1998 +
23 1928 M 1996 +
24 1937 W 1997 +
25 1941 W 2003
26 1944 W 1996
27 1932 M 1998
28 1925 M 2003
29 1945 W 1995 +
30 1929 M 1998
31 1944 W 1998
32 1936 W 1998
33 1947 M 2003 +
M = man, W = woman 
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Table 3. Trace element concentrations in serum from controls (n=99) and PD patients 
(n=33) in samples collected prediagnostically in 1995-97. Odds ratios (OR) and 95% 
confidence intervals (CI) for the multiple regression analysis are given together with the 
p-values.
Controls PD patients OR 95% CI p-value
Element Unit Average SD Average SD 
As μg/l 3.7 4.4 2.5 2.3 0.91 0.79-1.04 0.170
Ca mg/l 103 13 105 11 1.03 0.99-1.07 0.150
Co μg/l 0.149 0.154 0.118 0.057 0.98 0.93-1.04 0.548
Cr μg/l 0.75 1.57 0.60 1.26 0.95 0.60-1.50 0.818
Cu μg/l 1184 293 1119 230 0.97 0.82-1.13 0.662
Fe μg/l 1146 463 1275 551 1.74 0.73-4.17 0.216
Hg μg/l 0.48 0.25 0.40 0.15 0.69 0.50-0.97 0.031
Mg mg/l 21.4 3.0 22.0 3.0 1.17 0.99-1.39 0.068
Mn μg/l 2.08 1.07 2.09 0.81 1.06 0.66-1.69 0.821
Mo μg/l 0.91 0.41 1.07 0.43 3.13 0.87-11.25 0.081
Ni μg/l 0.46 0.66 0.45 0.42 1.48 0.60-3.38 0.397
Pb μg/l 0.34 0.49 0.29 0.43 0.98 0.88-1.08 0.640
Rb μg/l 185 36 172.1 27.9 0.99 0.98-1.01 0.355
Se μg/l 109.6 16.1 111.4 15.0 1.01 0.98-1.04 0.492
Sr μg/l 28.4 7.6 26.8 6.8 0.99 0.93-1.06 0.819
Tl μg/l 0.015 0.007 0.013 0.003 0.90 0.80-1.02 0.095
U μg/l 0.009 0.003 0.014 0.024 1.07 0.91-1.25 0.416
Y μg/l 0.030 0.013 0.029 0.010 1.01 0.97-1.05 0.577
Zn μg/l 992 304 994 311 1.00 0.87-1.14 0.969
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Table 4. Trace element concentrations in serum from the same patients collected before 
and after diagnosis with p-values from paired sample t-test. Statistically significant 
differences are indicated in italics 
Before diagnosis (1995) After diagnosis (2007) Paired sample t-test 
Element Unit Average SD Average SD p-value
As μg/l 3.3 2.7 2.5 3.0 0.269
Ca mg/l 104 13 89 9 0.001
Co μg/l 0.136 0.066 0.292 0.501 0.240
Cr μg/l 0.99 1.76 1.40 1.29 0.233
Cu μg/l 1152 282 1116 258 0.497
Fe μg/l 1130 428 949 325 0.023
Hg μg/l 0.39 0.13 0.56 0.31 0.010
Mg mg/l 21.7 3.5 20.7 2.5 0.003
Mn μg/l 2.02 0.50 1.27 0.81 0.000
Mo μg/l 1. 07 0.44 1.01 0.51 0.943
Ni μg/l 0.39 0.35 1.14 0.50 0.006
Pb μg/l 0.34 0.52 0.16 0.40 0.637
Rb μg/l 170 27 153 37 0.050
Se μg/l 109.8 16.9 73.0 18.3 0.000
Sr μg/l 25.9 5.3 28.1 12.7 0.101
Tl μg/l 0.013 0.004 0.013 0.006  0.128
U μg/l 0.010 0.002 0.022 0.009 0.768
Y μg/l 0.031 0.013 0.098 0.039 0.000
Zn μg/l 1026 323 964 360 0.336
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